Engineering Disulfide Cross‐Links in RNA Via Air Oxidation by Maglott, Emily J. & Glick, Gary D.
UNIT 5.4Engineering Disulfide Cross-Links in RNA
Via Air Oxidation
This unit describes methods for the synthesis of thiol-modified ribonucleosides, their
incorporation into synthetic RNA, and the formation of intramolecular disulfide bonds in
RNA by air oxidation. The disulfide bonds can be formed in quantitative yields between
thiols positioned in close proximity in either RNA secondary or tertiary structure.
Disulfide cross-links are useful tools to probe solution structures of RNA, monitor
dynamic motions, and stabilize folded RNAs.
Several steps are involved in the successful formation of a disulfide-cross-linked RNA.
First, a location for incorporation of the disulfide bond is selected (Glick, 1998). For best
results, this should be based on the highest-resolution structural data available for the
particular RNA. In most cases, it is desirable to avoid interfering with interactions that
stabilize structure, such as hydrogen bonding. Once the site for the disulfide bond has
been chosen, the necessary thiol-modified nucleosides must be chemically synthesized.
In most cases, the authors use alkylthiol linkers on the 2′ hydroxyl and the N3 position of
pyrimidine residues, although linkers can be positioned at nearly any position of a
nucleoside. The thiol-modified nucleoside phosphoramidites are synthesized with the
thiol functionality protected as a tert-butyl disulfide, a protecting group that is stable under
all conditions of solid-phase synthesis and subsequent manipulations.
Incorporation of the thiol-modified nucleosides is accomplished by solid-phase chemical
synthesis of the RNA. Following removal of both the exocyclic amine-protecting groups
and the tert-butyldimethyl silyl groups used to protect the 2′ hydroxyls, the full-length
oligoribonucleotide is purified by denaturing polyacrylamide gel electrophoresis (PAGE).
Reduction of the mixed disulfide with dithiothreitol (DTT) liberates the free thiols. These
are then oxidized by vigorous stirring in air to form an intramolecular disulfide bond in
quantitative yield.
The Basic Protocol describes the procedures for formation of intramolecular disulfide
bonds by air oxidation of thiol-mediated RNA. Optimized protocols for solid-phase
synthesis and deprotection of tRNAs (tRNA is used here as a model RNA) containing
thiol-modified residues are presented in Support Protocol 1. Support Protocol 2
describes a method for purification of tRNAs containing thiol-modified residues.
Support Protocol 3 describes a fluorescence assay to quantify the concentration of free
thiol remaining during cross-link formation. Support Protocols 4, 7, and 8 describe
the synthesis of three different thiol-containing nucleoside phosphoramidites, while
Support Protocol 6 describes the synthesis of an intermediate compound needed for
Support Protocols 7 and 8. Support Protocol 5 details the preparation of a thiol-modi-
fied controlled-pore glass (CPG) support used in the solid-phase synthesis of the
modified RNA.
NOTE: All procedures should be conducted using sterile techniques. When handling the
RNA, suitable precautions should be taken to avoid RNase contamination. Gloves must
be worn during handling of all equipment. Treatment of solutions with DEPC to inactivate
RNases is not necessary, but could be done if preferred.
CAUTION: Acrylamide is a neurotoxin, minimize inhalation and skin exposure. The
reagents and solvents used in both solid-phase RNA synthesis and the synthesis of the
thiol-modified phosphoramidites should be handled according to the manufacturer’s
safety data sheet for each reagent.
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BASIC
PROTOCOL
FORMATION OF INTRAMOLECULAR DISULFIDE CROSS-LINKS IN RNA
The RNA used in this protocol has been synthesized with the thiol groups protected as
tert-butyl disulfides. Liberation of the free thiols is achieved by reduction of the mixed
disulfides with DTT or other reducing agents, such as glutathione. Following removal of
the DTT by continuous flow dialysis, the intramolecular disulfide bond is formed in the
dilute RNA solution by air oxidation in a mildly basic solution (e.g., pH 8.0).
Materials
tert-Butyl-disulfide-modified RNA (see Support Protocol 1)
100 mM sodium phosphate buffer, pH 8.3 (see recipe)
Dithiothreitol (DTT)
Sodium phosphate buffer/NaCl, pH 7.0 (see recipe)
5000-molecular-weight-cutoff (MWCO) cellulose ester membrane
200 mM MgCl2 (see recipe)
0.1 N NaOH
TE buffer (APPENDIX 2A)
1.5 M sodium acetate (NaOAc), pH 5.5
Absolute ethanol
10-well (500 µL) microdialyzer (e.g., Spectrum)
0.2-µm bottle-top filter
Argon (Ar) tank
Peristaltic pump
70°C water bath
pH meter with microelectrode
Additional reagents and equipment for denaturing polyacrylamide gel
electrophoresis (e.g., CPMB UNIT 7.6 and APPENDIX 3B of this manual) or for
derivatization and fluorescence spectroscopy for quantitation of thiols (see
Support Protocol 3)
Remove tert-butyl disulfide protecting groups to liberate free thiols
1. In a 0.5-mL microcentrifuge tube, dissolve the tert-butyl-disulfide-modified RNA
(0.5 OD260 U) to a concentration of 50 µM in 16 µL of 100 mM sodium phosphate
buffer, pH 8.3.
2. Add 0.054 mg DTT (200 eq per disulfide), close the tube, and incubate the mixture
at 25°C for 12 hr.
The authors have found that between 12 and 14 hr of incubation effects complete reduction
of the tert-butyl disulfide protecting groups. This can be conveniently conducted overnight.
3. Open the tube and dilute the reaction mixture with 100 µL sodium phosphate
buffer/NaCl, pH 7.0.
4. Assemble a 10-well continuous-flow microdialyzer with a 5000-MWCO cellulose
ester membrane following the manufacturer’s instructions.
Other types of dialysis assemblies should work as well.
5. Filter 3 L sodium phosphate buffer/NaCl through a 0.2-µm bottle-top filter and sparge
the filtered buffer with Ar for ≥30 min before use.
6. Fill the dialysis chamber with sodium phosphate buffer/NaCl, removing all air
bubbles from under the wells by forcing them out one of the flow ports as the chamber
fills.
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7. Transfer the reduced RNA to a well of the microdialyzer and rinse the reaction tube
with phosphate buffer/NaCl, adding the rinsings to the dialyzer well. Dialyze the
RNA against the same buffer at a flow rate of 5.0 mL/min for 10 hr at room
temperature.
Control experiments show that this method completely removes the DTT.
8. Transfer the dialyzed RNA sample from the dialyzer well to a 1.5-mL microcentri-
fuge tube. Rinse the well of the dialyzer with 100 to 200 µL of sodium phosphate
buffer/NaCl and add to the RNA sample.
Form intramolecular disulfide bonds via air oxidation
9. Dilute the reduced, dialyzed tRNA sample to a final RNA concentration of 1 to 4 µM
with sodium phosphate buffer/NaCl to prevent intermolecular disulfide bonds from
forming.
10. Add 200 mM MgCl2 stock solution to 5 mM final concentration. Fold the RNA by
heating the RNA sample to 70°C for 2 min in a water bath and then allowing the
sample to cool to room temperature (15 to 30 min).
This procedure has been optimized for yeast tRNAPhe samples; details of the folding
protocol (i.e., time and temperature for refolding, with Mg2+ concentration) will be different
for other RNAs.
11. Calibrate a microelectrode at pH 7.0. Immerse the electrode in the RNA sample.
Adjust the pH of the sample to 8.0 with 0.1 N NaOH (typically 3 to 5 µL for a 400-µL
sample).
12. Stir the RNA solution at room temperature exposed to air, loosely covering the tubes
with a paper towel to minimize dust contamination.
13. Monitor disulfide bond formation by removing 5-µL aliquots of the reaction mixture
and assessing them either by denaturing PAGE (e.g., CPMB UNIT 7.6) or by fluorescence
spectroscopy after derivatization with 7-diethylamino-3-(4′-maleimidylphenyl)-4-
methylcoumarin (see Support Protocol 3). Disulfide bond formation is usually
complete in ≤12 hr.
Progress of cross-linking can be monitored throughout; however frequent monitoring is
time-consuming and will decrease final yields.
Cross-linked RNAs have slower gel mobility than the non-cross-linked RNAs (Sigurdsson
and Eckstein, 1996).
The fluorescence assay using 7-diethylamino-3-(4′-maleimidylphenyl)-4-methylcoumarin
(Parvari et al., 1983) is more sensitive than with Ellman’s reagent.
14. Conduct native gel electrophoresis (e.g., CPMB UNIT 2.7) to verify formation of intra-
molecular cross-links.
15. Dialyze the cross-linked RNA against 1 L TE buffer using continuous-flow microdia-
lysis as described in steps 4 to 8.
 Do not precipitate directly from the phosphate buffer, as recovered yields will be poor.
Disulfide cross-link formation is usually quantitative, as judged by ethidium bromide
staining of a sample analyzed by PAGE, and purification to remove non-cross-linked RNA
is not necessary. 
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Purify RNA from eluate
16. Add 1⁄5 vol of 1.5 M NaOAc, pH 5.5, and 3 vol absolute ethanol. Mix thoroughly and
place at –20°C overnight.
17. Centrifuge 1 hr at 16,000 × g, 4°C.
18. Decant the solution and dry the pellet of RNA under vacuum.
19. Combine the RNA into one tube by dissolving the pellets in water and transferring
to one tube. Rinse the tubes at least 3 times with water to ensure transfer of all
RNA. Evaporate the RNA solutions dryness under vacuum and store at –20°C
until use.
20. Store the precipitated RNA at −20°C (stable at least 1 year).
SUPPORT
PROTOCOL 1
SYNTHESIS OF RNA CONTAINING tert-BUTYLDISULFIDE-MODIFIED
NUCLEOSIDES BY SOLID-PHASE METHODS
Incorporation of modified nucleosides into an RNA can be accomplished with the
necessary phosphoramidites and solid-phase synthesis technology. The following proce-
dure has been optimized to use standard, commercially available ribonucleoside phos-
phoramidites and reagents combined with thiol-modified nucleoside phosphoramidites
to allow total chemical synthesis of RNAs at least 76 nucleotides long. Careful handling
to minimize exposure of the phosphoramidites and reagents to moisture throughout the
procedure enables milligram quantities of 76-mer RNAs containing modified nucleosides
to be obtained from a single 1-µmol-scale synthesis.
Materials
Methylene chloride (CH2Cl2) in CaH2
Acetonitrile (CH3CN) in CaH2
Thiol-modified nucleoside phosphoramidites (see Support Protocols 4, 7, and 8)
Nucleoside phosphoramidites
Argon (Ar)
Anhydrous ethanol
Absolute ethanol, room temperature and –20°C
Brine (saturated aqueous NaCl)
Nitrogen (N2) stream
Ammonia gas (NH3)
1.0 M tetrabutylammonium fluoride (TBAF) in tetrahydrofuran (THF)
1.5 M sodium acetate (NaOAc), pH 5.5 (see recipe)
Ethyl acetate (EtOAc)
Rotoevaporator
Automated nucleic acid synthesizer
Trap-Pak molecular sieve bags (Perseptive Biosystems)
Rubber septa
Cannula
CPG column loaded with appropriate nucleoside (purchased, or see Support
Protocol 5)
Desiccator
1- and 2-dram glass vials (oven dried >8 hr at 180°C)
Teflon tape
Dry bath, 55°C
Speedvac evaporator or equivalent
Spatula, RNase-free
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5-in. (12.5-cm) glass pipets
Rotary shaker
Prepare thiol-modified phosphoramidites for automated synthesis
1. At least 24 hr before beginning the RNA synthesis, distill 1 L CH2Cl2 and 100 mL
CH3CN from CaH2.
2. Dry the necessary thiol-modified phosphoramidites by coevaporation with distilled
CH3CN (~1 mL/50 mg) three times, then under high vacuum overnight.
The quantity of phosphoramidite depends on both the RNA sequence (if the same or
different nucleosides are used) and the number of sequences being synthesized at one time.
One coupling typically takes 5 mg dissolved in 5 mL on a Perkin-Elmer Expedite 8909
synthesizer.
3. Prepare the automated nucleic acid synthesizer for RNA synthesis following the
manufacturer’s suggested protocols.
Replacing all reagent solutions on the synthesizer with newly opened bottles of reagents
immediately prior to use significantly improves both the quality and the yield of the
synthesis. Although commercial preparations of 3% TCA can be used, it is recommended
that solutions of 3% TCA be made with freshly distilled CH2Cl2 immediately prior to
synthesis. The use of Trap-Pak molecular sieve bags to remove residual water in the solvent
in CH3CN solutions (one Trap-Pak per liter) is also recommended.
The protocols described here have been conducted with both AN-Bz, CN-Bz, GN-iBu, and U
5′-O-dimethoxytrityl, 2′-O-tert-butyldimethylsilyl, 3′-O-diisopropyl-β-cyanoethyl phos-
phoramidites as well as AN-Pac and GN-Pac 5′-O-dimethoxytrityl, 2′-O-tert-butyldimethyl-
si lyl ,  and 3′-O-diisopropyl-β-cyanoethyl phosphoramidites. Other exocyclic
amine-protecting groups should also be suitable for these protocols.
4. Backfill the flask(s) containing the thiol-modified phosphoramidite(s) with Ar and
quickly seal with a rubber septum.
5. Working under Ar, dilute the thiol-modified phosphoramidite(s) with distilled
CH3CN to 50 mg/mL. Using a cannula, place the solution into an oven-dried bottle
of appropriate size for the synthesizer and place on the synthesizer.
This amidite concentration is recommended for an Expedite 8909 synthesizer (Perseptive
Biosystems). Other synthesizers will also work; amidites should be diluted according to
the manufacturer’s protocols.
6. Prime the delivery lines with all ancillary reagents twice, and then prime the delivery
lines with the amidite solutions twice, to ensure that the flow lines from each bottle
of reagent and from the amidite bottle are filled.
7. Place a CPG column loaded with the appropriate nucleoside onto the synthesizer.
See Glick (1991) for details on the loading of thiol-modified supports.
8. Begin the RNA synthesis following the manufacturer’s protocols.
Addition of CH2Cl2 wash steps both before and after TCA treatment improves coupling
efficiencies (see Goodwin et al., 1996).
RNA synthesis is very sensitive to water. Eliminate water from all reagents and handling
procedures as much as possible. The use of freshly distilled CH3CN and CH2Cl2 and newly
opened dry reagents improves coupling efficiencies and allows the synthesis of RNAs
exceeding 75 residues. It is also recommended that phosphoramidites be handled under an
Ar atmosphere in a glove bag, especially in humid conditions. While solutions of A, C, and
U phosphoramidites are stable for at least 5 days, the coupling efficiency of G phos-
phoramidites is increased with fresh dilution on a daily basis. A typical RNA coupling cycle
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takes 15 min (Gait et al., 1991; Goodwin et al., 1994). The synthesis of one 76-mer tRNA
sequence takes ∼19.5 hr.
Deprotect synthetic RNA
9. Cool a 2-dram oven-dried vial under N2.
10. Add 2 to 3 mL anhydrous ethanol to the vial and cool in a brine/ice water bath under
N2 for 2 to 5 min.
11. Remove the N2 line and insert a needle attached to a lecture bottle of NH3 and a vent.
Saturate the ethanol by constant bubbling with NH3 for at least 30 min.
This procedure should be conducted in a fume hood.
12. Open the synthesis column and pour the solid support into a 1-dram oven-dried vial.
13. Quickly pour ∼1 mL of the anhydrous ethanolic ammonia solution into the vial. Seal
threads of the vial with Teflon tape and cap tightly. Seal the outside of the cap with
Teflon tape and parafilm to prevent evaporation.
The inner Teflon tape can be put on the vial before pouring the solution, but be careful not
to pour the ethanolic ammonia onto the tape or the seal will not be adequate. Usually
bubbling occurs as the solution is poured onto the resin.
14. Place the sealed vial in a 55°C dry bath for 18 hr.
15. Remove the vial from the dry bath and allow to cool to room temperature before
opening. Carefully open the vial and pass a gentle stream of N2 over the solution for
5 to 15 min to remove the ammonia.
When the cap is removed, there should be a small release of pressure; this indicates that
the ethanolic ammonia solution was thoroughly saturated during deprotection.
A significant portion of the ethanol may evaporate during this procedure. If the solution
becomes viscous (typically, with less than ∼300 L ethanol remaining), add 500 L of
anhydrous ethanol to the vial before proceeding to step 16.
16. Transfer the ethanol solution from the vial to an autoclaved 1.5-mL microcentrifuge
tube and evaporate under vacuum to ≤400 µL total volume. Transfer any remaining
solution to the microcentrifuge tube and then rinse the solid support with 500 µL
anhydrous ethanol. Add the rinsing to the microcentrifuge tube and evaporate the
solution under vacuum to ≤400 µL.
17. Thoroughly rinse the solid support with anhydrous ethanol five more times using 100
to 200 µL ethanol each time, adding the rinsings to the microcentrifuge tube.
Evaporate the solution to dryness under vacuum. Coevaporate with 500 µL anhydrous
ethanol. Repeat the coevaporation once more using 200 µL ethanol.
The residue resulting from step 17 may be stored for a few days at −20°C before proceeding
with the remainder of this protocol.
Desilylate synthetic RNA
18. Cool a 1-dram oven-dried vial in a desiccator.
19. Gently loosen the residue obtained after step 17 from the microcentrifuge tube with
the tip of an RNase-free spatula. Carefully transfer the residue to the dried vial.
20. Add ∼400 µL of 1.0 M TBAF in THF to the microcentrifuge tube with a glass pipet.
Vortex, centrifuge, and transfer the solution to the vial with a glass pipet. Repeat this
rinsing procedure twice more using ∼300 µL TBAF each time.
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TBAF solutions should be of the highest purity and lowest water content possible. For
optimal results, bottles of TBAF should only be used once. TBAF is light sensitive.
21. Seal the vial with Teflon tape, parafilm, and cover in foil. Place the vial on a rotary
shaker and shake at low speed for 24 hr.
22. Open the vial and quench the reaction with 1 mL of 1.5 M NaOAc, pH 5.5. Transfer
the solution in two approximately equal aliquots into two 1.5-mL microcentrifuge
tubes. Rinse the vial 5 times with 150 µL water and add the rinsings to the tubes.
23. Evaporate the solutions to ∼600 µL total volume in each tube. Add 600 to 700 µL
EtOAc to each tube and homogenize as thoroughly as possible. Centrifuge to separate
the layers. Remove the upper layer (EtOAc) with a pipet and repeat the extraction a
second time. Evaporate the solution under vacuum for ∼10 min to remove residual
EtOAc.
24. Transfer about half of the solution in each tube to another 1.5-mL microcentrifuge
tube, resulting in four tubes containing ∼300 µL solution each.
25. Add 1 mL absolute ethanol to each tube, mix thoroughly, and place at −20°C overnight.
26. Centrifuge all tubes for at least 1 hr at 16,000 × g, 4°C. Decant the supernatant from
the pellet and then wash the pellet with 200 µL of –20°C absolute ethanol. Dry the
pellet under vacuum.
27. Quantify the crude RNA by dissolving the pellets in water and measuring the
absorbance of a 1-µL aliquot of the solution at 260 nm. Estimate the molar extinction
coefficient (ε260) using nearest-neighbor calculations.
The ε260 calculation is done as described by Breslauer et al. (1986); see UNIT 7.3.  This
assumes that the modified residues behave like their unmodified counterparts.
Both crude and purified RNA samples should be stored either pelleted from ethanol
precipitation or dried down from aqueous solutions at −20°C.
28. Purify the crude RNA to single-nucleotide resolution (see Support Protocol 2).
SUPPORT
PROTOCOL 2
PURIFICATION OF SYNTHETIC RNA CONTAINING
tert-BUTYLDISULFIDE PROTECTED THIOL-MODIFIED NUCLEOSIDES
Single-nucleotide resolution of the products resulting from solid-phase synthesis, the full-
length oligomer as well as failed sequences, can be achieved using denaturing PAGE (also
see APPENDIX 3B). The procedures that are outlined have been optimized for the purification
of a 76-mer tRNA sequence. These protocols can be modified for sequences of other
lengths by adjusting the percentage of acrylamide in the gel matrix until both the
full-length RNA and the sequence resulting from incomplete synthesis one residue from
the end are resolved.
Materials
Crude synthetic tRNA (see Support Protocol 1)
80% formamide containing 0.05% xylene cyanol (XC) tracking dye
8% denaturing polyacrylamide solution (see recipe)
1× TBE electrophoresis buffer (APPENDIX 2A)
1× and 4× TAE electrophoresis buffer (APPENDIX 2A)
1.5 M sodium acetate (NaOAc), pH 5.5
Absolute ethanol
Power supply
Silica-gel plate
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UVG-11 Mineralight lamp (254 nm, 115 V) or equivalent
Razor blade, RNase free
Hoefer Six-Pac electroeluter or equivalent
Inner elution tubes
Porous polyethylene plugs
Blotter-paper discs
Additional reagents and equipment for denaturing polyacrylamide gel
electrophoresis (e.g., see CPMB UNIT 7.6 and APPENDIX 3B of this manual)
Separate RNA species by PAGE
1. Dissolve 20 to 40 OD260 U of crude synthetic tRNA in 60 µL water, mix thoroughly,
and allow to stand for ∼1 hr to thoroughly dissolve the RNA.
There will probably also be insoluble material present.
2. Add 60 µL of 80% formamide/0.05% XC and centrifuge briefly to separate the
insoluble matter.
3. Prepare an 8% denaturing polyacrylamide gel 31.0 cm × 38.5 cm × 0.8 mm, with
14.6-mm-wide wells (e.g., see CPMB UNIT 7.6 and APPENDIX 3B).
Electrophoresis conditions are outlined for the purification of a 76-nt tRNA sequence. For
sequences of different lengths, adjust the percentage acrylamide and electrophoresis time
accordingly.
4. Load 20 µL of the RNA sample into each of six wells, being careful not to load any
insoluble material onto the gel.
5. Electrophorese the gel in 1× TBE at 55 W until the XC tracking dye has migrated
∼11 inches (∼4 to 4.5 hr).
Under these conditions 76-mer RNA migrates with the XC—be careful not to run the RNA
off the gel.
Electroelute full-length synthetic RNA from gel slice
6. Place the gel over a silica-gel plate in a dark location. Briefly shine 254-nm light on
the gel to locate the RNA. With a clean RNase-free razor blade, excise the full-length
RNA from the gel.
RNA is photoreactive; minimize exposure of RNA to UV light.
7. Pack the RNA slices into three or four inner elution tubes containing 300 µL of 1×
TAE using blotter-paper discs and porous polyethylene plugs according to manufac-
turer’s directions. Cut off the bottom tip of the inner elution tube and insert into a
1.5-mL microcentrifuge tube containing 200 µL of 4× TAE. Electroelute in a Hoefer
Six-Pac eluter for 90 min at +50 V.
For efficient electroelution, remove all air bubbles from the inner elution tubes. Also, the
elutions work better if the inner elution tubes are packed tightly with gel slices, but it is
important not to crush the slices. If the amperage does not decrease below 0.2 mA during
the course of electroelution, the gel slices can be recovered from the inner elution tube and
soaked in 400 L of 4× TAE at room temperature overnight. The eluted RNA should then
be ethanol precipitated as described in the next step and combined with the RNA eluted
during electroelution.
8. Remove the inner elution tube carefully, rinse the electrode with 20 µL water, and
add to the eluted RNA. Remove the electrode and pipet all buffer remaining above
the porous plug into the eluted RNA.
The total volume should be ∼350 L.
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Purify RNA from eluate
9. Add 70 µL of 1.5 M NaOAc, pH 5.5, and 1 mL absolute ethanol. Mix thoroughly and
place at −20°C overnight.
10. Centrifuge 1 hr at 16,000 × g, 4°C.
11. Decant the solution and dry the pellet of RNA under vacuum.
12. Combine the RNA into one tube by dissolving the pellets in water and transferring
to one tube. Rinse the tubes at least 3 times with water to ensure transfer of all RNA.
Evaporate the RNA solutions dryness under vacuum and store at −20°C until use
(stable at least 1 year).
SUPPORT
PROTOCOL 3
QUANTIFICATION OF THIOLS IN RNA USING
7-DIETHYLAMINO-3-(4′-MALEIMIDYLPHENYL)-4-METHYLCOUMARIN
Reaction of free thiols with 7-diethylamino-3-(4′-maleimidylphenyl)-4-methylcoumarin
produces a fluorescent adduct that can be quantified spectroscopically (Parvari et al.,
1983). This provides a convenient method to determine when the cross-linking reaction
is complete. The method can be used to accurately determine thiol concentrations as low
as 0.5 µM.
Materials
RNA solution containing free thiols (see Basic Protocol)
5× CPM buffer (see recipe)
0.4 mM CPM in isopropyl alcohol (see recipe)
1% Triton X-100
Sodium phosphate buffer/NaCl, pH 7.0 (see recipe)
Fluorimeter and cuvette
1. To a 5-µL aliquot of an RNA solution containing free thiols, add 1 µL of 5× CPM
buffer and 5 µL of 0.4 mM CPM in isopropyl alcohol. Incubate the sample 10 min
at room temperature.
2. Dilute the reaction with 489 µL of 1% Triton X-100.
3. Prepare a blank consisting of:
5 µL sodium phosphate buffer/NaCl, pH 7.0
1 µL 5× CPM buffer
5 µL 0.4 mM CPM in isopropyl alcohol
489 µL Triton X-100.
4. Transfer blank solution to a fluorimeter cuvette and measure the fluorescence
intensity at 480 nm (λex = 390 nm).
5. In the same way, measure the fluorescence intensity of the RNA solution from step
2, and correcting for background fluorescence.
A calibration curve can be constructed using DTT as a standard (0.5 to 5 mM is a useful
range).
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SUPPORT
PROTOCOL 4
SYNTHESIS OF 5′-O-(4,4′-DIMETHOXYTRITYL)-2′-O-(tert-
BUTYLDIMETHYLSILYL)-N3-(ETHYL)URIDINE-3′-O-(N,N-DIISOPROPYL-
β-CYANOETHYLPHOSPHORAMIDITE) tert-BUTYL DISULFIDE (S.5)
The preparation of a thiol-containing nucleoside phosphoramidite modified at the N3
position of uridine is described. The synthesis of 5′-O-(4,4′-dimethoxytrityl)-2′-O-(tert-
butyldimethylsilyl)-N3-(ethyl)uridine-3′-O-(N,N-diisopropyl-β-cyanoethylphosphoram
idite) tert-butyl disulfide (S.5) proceeds in four sets of steps from uridine (Fig. 5.4.1). The
3′-O-tert-butyldimethylsilyl-protected isomer (S.4) obtained as a side product of the third
set of steps is used to make a thiol-modified controlled-pore glass (CPG) support (Fig.
5.4.2; see Support Protocol 5).
Materials
Uridine
Distilled acetonitrile (CH3CN)
Distilled triethylamine (Et3N)
N,N-Dimethylformamide (DMF)
Chlorotrimethylsilane (TMSCl)
N2
Petroleum ether
Diethyl ether (Et2O)
Sodium hydride (NaH)
1-Tosyl-2-benzoylmercaptoethanol (see Glick et al., 1991)
48% (w/v) aqueous HF
Methylene chloride (CH2Cl2)
Brine (saturated aqueous NaCl)
Sodium sulfate (Na2SO4)
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Figure 5.4.1 Synthesis of 5′-O-(4,4′-dimethoxytrityl)-2′-O-(tert-butyldimethylsilyl)-N3-(ethyl)urid-
ine-3′-O-(N,N-diisopropyl-β-cyanoethylphosphoramidite) tert-butyl disulfide. (a) TMSCl, Et3N, DMF;
(b) NaH, DMF; (c) p-TsOCH2CH2SBz, DMF; (d) HF (aq); (e) DMTrCl, pyridine; (f) 1-(tert-butylthio)-
1,2-hydrazinedicarboxmorpholide, LiOH, CH3OH; (g) TBDMSCl, imidazole, DMF; (h) chloro-N,N-
diisopropylamine-β-cyanoethyl phosphine, 2,4,6-collidine, N-methylimidazole, THF. Abbreviations:
Bz, benzoyl; DMF, dimethylformamide; DMTr, 4,4′-dimethoxytrityl; TBDMS, tert-butyldimethylsilyl;
THF, tetrahydrofuran; Ts, tosyl.
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Methanol (CH3OH)
Pyridine
4,4′-Dimethoxytrityl chloride (DMTrCl)
1-(tert-Butylthio)-1,2-hydrazine carboxmorpholide (see Wünsch et al., 1982)
LiOH⋅H2O
Ethyl acetate (EtOAc)
Imidazole
tert-Butyldimethylsilyl chloride (TBDMSCl)
Tetrahydrofuran (THF)
2,4,6-Collidine
N-Methylimidazole
Chloro-N,N-diisopropylamine-β-cyanoethyl phosphine
Additional reagents and equipment for flash chromatography (APPENDIX 3E)
Prepare N3-(2-thiobenzoylethyl)uridine (S.1)
1. Dry 24.42 g uridine (100 mmol) by coevaporation with distilled CH3CN.
2. Dissolve the dried uridine in 83.6 mL freshly distilled Et3N (600 mmol, 6 eq) and
250 mL DMF.
3. Cool the solution to 4°C.
4. Slowly add 42 mL chlorotrimethylsilane (330 mmol, 3.3 eq) and stir the reaction
under N2 for 2 hr.
5. Remove salts that precipitate during the course of the reaction by filtration under N2.
6. Triturate the residual salts in the filtrate with 1:1 (v/v) petroleum ether/diethyl ether.
7. Dissolve the residue in 400 mL DMF and cool to 4°C.
8. Add 4.40 g NaH (110 mmol, 1.1 eq) to the reaction mixture with stirring under N2.
9. After hydrogen evolution subsides, add 37 g 1-tosyl-2-benzoylmercaptoethanol (110
mmol, 1.1 eq) and stir the reaction overnight at 45°C.
This step is based on the procedure detailed by Glick (1991).
10. Cool the solution to room temperature and remove the silyl groups by the addition
of 5 mL of 48% aqueous HF.
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Figure 5.4.2 Synthesis of 5′-O-(4,4′-dimethoxytrityl)-3′-O-(tert-butyldimethylsilyl)-2′-O-succinyl-
CPG N3-(ethyl)uridine tert-butyl disulfide. (a) succinic anhydride, DMAP, pyridine; (b) pentachlo-
rophenol, DCC, DMAP, CH2Cl2; (c) CPG (1000 Å), Et3N, DMF. Abbreviations: DCC,
dicyclohexyl-carbodiimide; DMAP, 4-dimethylaminopyridine; DMF, dimethylformamide; DMSO, di-
methyl sulfoxide.
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11. After 1 hr, dilute the reaction mixture with CH2Cl2 and wash successively with water
and brine.
12. Dry the organic layer over Na2SO4 and concentrate under vacuum.
13. Purify the oily residue by flash chromatography (APPENDIX 3E) using 19:1 (v/v)
CH2Cl2/CH3OH to obtain S.1 as a white foam (26 g, 63% yield).
Prepare 5′-O-(4,4′-dimethoxytrityl)-N3-(ethyl)uridine tert-butyl disulfide (S.2)
14. Coevaporate 15.0 g compound S.1 (37 mmol) once from 100 mL of 9:1 (v/v)
CH3CN/pyridine, then dissolve in 185 mL pyridine.
15. Add 15.0 g 4,4′-dimethoxytrityl chloride (44 mmol, 1.2 eq) in 2.5-g portions over a
6-hr period at 4°C with stirring.
16. Allow the reaction to warm to room temperature overnight while stirring under N2.
17. Add 5 mL CH3OH and stir the mixture an additional 10 min.
18. Remove the solvents under vacuum, and coevaporate the residue with 100 mL CH3CN
to yield a light yellow-orange foam.
19. Dissolve the crude tritylated product (14 g, 20 mmol) in 100 mL CH3OH and add
8.31 g 1-(tert-butylthio)-1,2-hydrazinedicarboxmorpholide (Wünsch et al., 1982) (24
mmol, 1.2 eq) and 2.52 g LiOH⋅H2O (60 mmol, 3.0 eq).
20. Stir the reaction under N2 for 12 hr and then concentrate the mixture under vacuum.
21. Dissolve the residue in EtOAc and wash with brine.
22. Dry the organic layer over Na2SO4 and concentrate under vacuum.
23. Purify the residue by flash chromatography (APPENDIX 3E) using a step gradient of 3:2
to 2:3 (v/v) petroleum ether/EtOAc to obtain S.2 as a white foam (9.7 g, 70% yield).
Prepare 5′-O-(4,4′-dimethoxytrityl)-2′-O-(tert-butyldimethylsilyl)-N3-(ethyl)uridine
tert-butyl disulfide (S.3) and 5′-O-(4,4′-dimethoxytrityl)-3′-O-(tert-butyldimethyl-
silyl)-N3-(ethyl)uridine tert-butyl disulfide (S.4)
24. Dissolve 9.5 g compound S.2 (13.6 mmol) in 50 mL DMF.
25. Add 2.31 g imidazole (34 mmol, 2.5 eq) and 2.58 g tert-butyldimethylsilyl chloride
(17.1 mmol, 1.25 eq).
26. Stir the mixture overnight under N2.
27. Dilute the reaction with EtOAc, wash the mixture with brine, dry over Na2SO4, and
evaporate under vacuum.
28. Purify the residue by flash chromatography (APPENDIX 3E) using 9:1 (v/v) petroleum
ether/EtOAc to obtain S.3 and S.4 as white foams (S.3: 3.9 g, 40% yield; S.4: 2.1 g,
25% yield).
Prepare 5′-O-(4,4′-dimethoxytrityl)-2′-O-(tert-butyldimethylsilyl)-N3-(ethyl)uridine-
3′-O-(N,N-diisopropyl-β-cyanoethylphosphoramidite) tert-butyl disulfide (S.5)
29. Dissolve 0.81 g compound S.3 (1.0 mmol) in 3.0 mL THF.
30. Add 1.0 mL 2,4,6-collidine (7.5 mmol, 7.5 eq) and 40 µL N-methylimidazole (0.5
mmol, 0.5 eq).
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31. Add 0.56 mL chloro-N,N-diisopropylamine-β-cyanoethyl phosphine (2.5 mmol, 2.5
eq) dropwise while stirring under N2.
32. After 2 hr, dilute the reaction with EtOAc and wash the mixture with NaHCO3 and
brine.
33. Dry the organic layer over Na2SO4, and concentrate under vacuum.
34. Purify the residue by flash chromatography (APPENDIX 3E) using 80:15:5 (v/v/v)
petroleum ether/EtOAc/Et3N to obtain S.5 as a brittle white foam (0.82 g, 82% yield).
SUPPORT
PROTOCOL 5
SYNTHESIS OF 5′-O-(4,4′-DIMETHOXYTRITYL)-3′-O-(tert-BUTYL-
DIMETHYLSILYL)-2′-O-SUCCINYL-CPG N3-(ETHYL)URIDINE tert-BUTYL
DISULFIDE CONTROLLED-PORE GLASS SUPPORT
5′-O-(4,4′-dimethoxytrityl)-3′-O-(tert-butyldimethylsilyl)-2′-O-succinyl-CPG N3-(ethyl)-
uridine tert-butyl disulfide (Fig. 5.4.2), a thiol-modified controlled-pore glass (CPG)
support, is prepared using a side product (S.4) obtained in Support Protocol 4. This
nucleoside support can be used to introduce a thiol modification at the 3′ terminus of an
RNA species. The nucleoside loading concentration is usually 32 µmol/g (Schaller et al.,
1963).
Materials
Compound S.4 (see Support Protocol 4)
Pyridine
Succinic anhydride
4-Dimethylaminopyridine (DMAP)
Methylene chloride (CH2Cl2)
Brine (saturated aqueous NaCl)
Sodium sulfate (Na2SO4)
Pentachlorophenol
Dicyclohexylcarbodiimide (DCC)
Petroleum ether
Ethyl acetate (EtOAc)
Long-chain alkyl amino controlled-pore glass (CPG), 1000-Å pore size, 100 µmol
amino groups/g, 120/200 mesh
N,N-Dimethylformamide (DMF)
Triethylamine (Et3N)
Methanol (CH3OH)
Diethyl ether (Et2O)
Acetic anhydride
Additional reagents and equipment for flash chromatography (APPENDIX 3E)
Prepare 5′-O-(4,4′-dimethoxytrityl)-3′-O-(tert-butyldimethylsilyl)-2′-O-pentachlo-
rophenylsuccinate N3-(ethyl)uridine tert-butyl disulfide (S.6)
1. Dissolve 1.77 g compound S.4 (2.2 mmol) in 12.0 mL pyridine under N2.
2. Add 0.69 g succinic anhydride (6.6 mmol, 3.0 eq) and 0.133 g DMAP (1.1 mmol, 0.5
eq) and incubate 12 hr.
3. Concentrate the reaction mixture under vacuum.
4. Dissolve the residue in CH2Cl2 and wash with brine.
5. Dry the organic layer over Na2SO4 and concentrate under vacuum.
Current Protocols in Nucleic Acid Chemistry
5.4.13
Methods for
Cross-Linking
Nucleic Acids
6. Dissolve the crude succinate in 25 mL CH2Cl2 and add 0.88 g pentachlorophenol (3.3
mmol, 1.5 eq), 67 mg DMAP (0.55 mmol, 0.25 eq), and 0.91 g DCC (4.4 mmol, 2.0
eq).
7. After 8 hr, add petroleum ether to precipitate dicyclohexylurea.
8. Gravity filter the reaction mixture and concentrate under vacuum.
9. Purify the residue by flash chromatography (APPENDIX 3E) using 4:1 (v/v) petroleum
ether/EtOAc to obtain S.6 as a white foam (2.3 g, 90% yield).
Prepare 5′-O-(4,4′-dimethoxytrityl)-3′-O-(tert-butyldimethylsilyl)-2′-O-succinyl-CPG
N3-(ethyl)uridine tert-butyl disulfide (S.7)
10. Suspend long-chain alkyl amino CPG in 4.0 mL DMF with 0.58 g compound S.6
(0.5 mmol, 5 eq) and 0.14 mL Et3N (1.0 mmol, 10 eq).
11. Gently swirl the mixture in the dark for 2 days.
12. Vacuum filter the support and rinse successively with 15 mL DMF, 50 mL CH3OH,
and 50 mL Et2O.
13. Remove the residual solvents under vacuum.
14. Acetylate the unreacted amino groups by swirling the support for 1 hr with 0.70 mL
acetic anhydride (7.0 mmol, 100 eq) and 10 mg DMAP (70 µmol, 1 eq) in 4 mL
pyridine.
15. Rinse the support successively with 30 mL pyridine, 90 mL CH3OH, and 90 mL Et2O.
16. Remove the residual solvents under vacuum.
SUPPORT
PROTOCOL 6
SYNTHESIS OF 3′,5′-O-(TETRAISOPROPYLDISILOXANE-1,3-DIYL)-2′-O-
ALLYL-O4-(2-NITROPHENYL) URIDINE (S.10) INTERMEDIATE
Preparation of thiol-modified nucleoside phosphoramidite modified at the 2′-hydroxyl
position of pyrimidines proceeds from preparation of 3′,5′-O-(tetraisopropyldisiloxane-
1,3-diyl)-2′-O-allyl-O4-(2-nitrophenyl)uridine. Preparation of this compound is de-
scribed. First, uridine is converted to 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-
O4-(2-nitrophenyl) uridine (S.9) in two sets of steps as described by Sproat and Lamond
(1991). This compound is then allylated using the procedure described by Sproat et al.
(1991).
Materials
Uridine
Pyridine
1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane
Methylene chloride (CH2Cl2)
Methanol (CH3OH)
Saturated aqueous sodium bicarbonate (NaHCO3)
Sodium sulfate (Na2SO4)
Triethylamine (Et3N)
Chlorotrimethylsilane
Brine (saturated aqueous NaCl)
2-Mesitylenesulfonyl chloride
4-Dimethylaminopyridine (DMAP)
2-Nitrophenol
1,4-Diazabicyclo[2.2.2]octane (DABCO)
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p-Toluenesulfonic acid monohydrate
p-Dioxane
Ethyl acetate (EtOAc)
Petroleum ether
Tetrahydrofuran (THF)
Triphenylphosphine
Tris(dibenzylideneacetone) dipalladium(0)
Allyl ethyl carbonate
Additional reagents and equipment for flash chromatography (APPENDIX 3E)
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-uridine (S.8)
1. Dissolve 499 mg uridine (2.04 mmol) in 5.1 mL pyridine.
2. Cool to 0°C under N2.
3. Dissolve 732 µL 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (2.29 mmol, 1.1 eq)
in 0.5 mL CH2Cl2 and add dropwise to uridine solution.
4. Stir the reaction, allowing it to warm to room temperature, for 4 hr.
5. Dilute the reaction by adding 0.4 mL CH3OH, and evaporate under vacuum.
6. Dissolve the residue in 15 mL CH2Cl2 and wash three times with saturated aqueous
NaHCO3.
7. Dry the organic layer over Na2SO4 and evaporate under vacuum.
8. Dissolve the residue in toluene and evaporate under vacuum to obtain S.8 as a white
foam (1.0 g, 100%).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-O4-(2-nitrophenyl) uridine (S.9)
9. Dissolve 3.4 g compound S.8 (6.9 mmol) in 35 mL CH2Cl2 and cool to 0°C.
It may be necessary to repeat the synthesis of S.8 to obtain the necessary quantity for the
synthesis of S.9.
10. Add 9 mL Et3N (64.6 mmol, 9.4 eq) followed by 6.4 mL chlorotrimethylsilane (50.4
mmol, 7.3 eq) and stir the reaction 4 hr under N2.
11. Pour the reaction onto 100 mL saturated aqueous NaHCO3 and stir for 10 min.
12. Wash the organic layer with brine, dry over Na2SO4, and concentrate under vacuum
to a peach foam (3.8 g, 100%).
13. Dissolve the residue in 36 mL CH2Cl2 and 4.8 mL Et3N (34.6 mmol, 5 eq).
14. Add 2.25 g 2-mesitylenesulfonyl chloride (10.3 mmol, 1.5 eq) and 0.5 g DMAP (3.5
mmol, 0.5 eq). Stir for 15 min.
15. Add 2.0 g 2-nitrophenol (14.4 mmol, 2.1 eq) and 0.42 g DABCO (3.7 mmol, 0.55
eq) and continue stirring for 3 hr.
16. Dilute the reaction with 40 mL CH2Cl2 and wash with saturated aqueous NaHCO3.
17. Backwash the aqueous layer twice with CH2Cl2.
18. Dry the combined organic layers over Na2SO4 and concentrate under vacuum.
19. Dissolve the residue in 21 mL CH2Cl2 and add a solution of 2.70 g p-toluenesulfonic
acid monohydrate in 21 mL p-dioxane.
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20. Stir the reaction for 2 min and then quench by adding 2.5 mL Et3N.
21. Pour the reaction onto saturated aqueous NaHCO3 and backwash the aqueous layer
with CH2Cl2 twice.
22. Dry the combined organic layers over Na2SO4 and concentrate under vacuum.
23. Purify the residue by flash chromatography (APPENDIX 3E) using 55% EtOAc in
petroleum ether to obtain S.9 (4.5 g, 6.9 mmol, 100%).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-2′-O-allyl-O4-(2-nitrophenyl)
uridine (S.10)
24. Dissolve the 4.5 g compound S.9 in 37 mL THF (37 mL).
25. Add 371 mg triphenylphosphine (1.4 mmol, 0.2 eq) and 168 mg tris(diben-
zylideneacetone) dipalladium(0) (0.2 mmol, 0.026 eq).
26. Add 1.9 mL allyl ethyl carbonate (14.0 mmol, 2 eq) dropwise.
27. Heat the reaction to reflux for 2 hr.
28. Cool the reaction to room temperature and concentrate under vacuum.
29. Purify the residue by flash chromatography (APPENDIX 3E) using 18% EtOAc in
petroleum ether to obtain S.10 (3.3 g, 72%).
SUPPORT
PROTOCOL 7
SYNTHESIS OF 5′-O-(4,4′-DIMETHOXYTRITYL)-N4-(BENZOYL)-2′-O-
(ETHYL)CYTIDINE-3′O-(N,N-DIISOPROPYL--CYANOETHYLPHOS-
PHORAMIDITE) tert-BUTYL DISULFIDE (S.20)
The intermediate prepared in Support Protocol 6 is converted to 3′,5′-O-(tetraiso-
propyldisiloxane-1,3-diyl)-N4-(benzoyl)-2′-O-allyl cytidine (S.11) using the method of
Sproat and Lamond (1991) replacing isobutyryl chloride with benzoyl chloride. The
synthesis of the fully protected phosphoramidite can be accomplished in nine sets of steps
(Fig. 5.4.3).
Materials
Compound S.10 (see Support Protocol 6)
Tetrahydrofuran (THF)
Ammonia (NH3)
N2
Methanol (CH3OH)
Petroleum ether
Ethyl acetate (EtOAc)
Pyridine
N,N-Dimethylformamide (DMF)
Benzoic anhydride
Ammonium hydroxide (NH4OH)
N-Methylmorpholine-N-oxide
Acetone
Osmium tetroxide (OsO4)
Saturated aqueous sodium bisulfite
Diethyl ether (Et2O)
Saturated aqueous sodium bicarbonate (NaHCO3)
Brine (saturated aqueous NaCl)
Sodium sulfate (Na2SO4)
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Figure 5.4.3 Synthesis of 5′-O-(4,4′-dimethoxytrityl)-N4-(benzoyl)-2′-O-(ethyl)cytidine tert-butyl
disulfide 3′-O-(N,N-diisopropyl-β-cyanoethylphosphoramidite). (a) pyridine, 1,3-dichloro-1,1,3,3-
tetraisopropyldisiloxane, CH2Cl2; (b) chlorotrimethylsilane, Et3N, CH2Cl2; (c) 2-mesitylenesulfonyl
chloride, DMAP, Et3N, CH2Cl2; (d) 2-nitrophenol, DABCO; (e) p-toluenesulfonic acid monohydrate,
p-dioxane, CH2Cl2; (f) triphenylphosphine, tris(dibenzylideneacetone) dipalladium(0), allyl ethyl
carbonate, THF; (g) NH3, THF; (h) pyridine, benzoic anhydride, DMF; (i) OsO4, N-methylmor-
pholine-N-oxide, acetone, H2O; (j) NaIO4, p-dioxane, H2O; (k) NaBH4, CH3OH; (l) methanesulfonyl
chloride, pyridine; (m) thiobenzoic acid, Et3N, DMF; (n) HF (aq), CH3CN; (o) 1-(tert-butylthio)-1,2-
hydrazinedicarboxmorpholide, LiOH, CH3OH, THF; (p) DMTrCl, Et3N, DMF, DMAP; (q) chloro-N,N-
diisopropylamine-β-cyanoethyl phosphine, N,N-diisopropylethylamine, CH2Cl2. Abbreviations: Bz,
benzoyl; DMAP, 4-dimethylaminopyridine; DMF, dimethylformamide; DMTr, 4,4′-dimethoxytrityl; Ms,
methanesulfonyl; THF, tetrahydrofuran.
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Methylene chloride (CH2Cl2)
p-Dioxane
Sodium periodate (NaIO4)
Sodium borohydrate (NaBH4)
Methanesulfonyl chloride
Triethylamine (Et3N)
Thiobenzoic acid
Acetonitrile (CH3CN)
48% (w/v) aqueous HF
1-(tert-Butylthio)-1,2-hydrazinedicarboxmorpholide (Wünsch et al., 1982)
LiOH⋅H2O
1 N aqueous sodium citrate
4-Dimethylaminopyridine (DMAP)
4,4′-Dimethoxytrityl chloride (DMTrCl)
N,N-Diisopropylethylamine
Chloro-N,N-diisopropylamine-β-cyanoethyl phosphine
Pressure tube (−78°C)
CO2/isopropyl alcohol (i-PrOH) bath
Additional reagents and equipment for flash chromatography (APPENDIX 3E)
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)- N4-(benzoyl)-2′-O-allyl cytidine
(S.11)
1. Dissolve 1.94 g compound S.10 (2.99 mmol) in 8.5 mL THF in a pressure tube.
2. Cool the tube to −78°C using a CO2/i-PrOH bath.
3. Add 5 g NH3 (299 mmol, 100 eq).
4. Seal the reaction vessel and stir while allowing it to warm to room temperature for
62 hr.
5. Cool the reaction mixture to −78°C using CO2/i-PrOH bath and open the pressure
tube.
6. Allow the mixture to warm under N2 to room temperature.
7. Concentrate under vacuum.
8. Purify the residue by flash chromatography (APPENDIX 3E) using a step gradient of 0
to 10% CH3OH in 7:3 (v/v) petroleum ether/EtOAc.
9. Dissolve the purified residue in 14 mL pyridine and 6.5 mL DMF.
10. Add 0.72 g benzoic anhydride (3.20 mmol, 1.5 eq) and stir the reaction under N2 for
12 hr at room temperature.
11. Cool the reaction to 0°C and add 0.4 mL water.
12. Stir the reaction 5 min at 0°C, then add 0.3 mL NH4OH.
13. Continue stirring the reaction 10 min at 0°C, then concentrate the mixture under
vacuum.
14. Purify the residue by flash chromatography (APPENDIX 3E) using 3:2 (v/v) petroleum
ether/EtOAc to obtain S.11 (1.42 g, 75% yield) as a white foam.
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Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)- 2′-O-(2,3-dihydroxypropyl)-
cytidine (S.12)
15. Dissolve 1.34 g compound S.11 (2.30 mmol) and 0.27 g N-methylmorpholine-N-ox-
ide (2.34 mmol, 1.1 eq) in 21 mL of 6:1 (v/v) acetone/water.
16. Add 5 mg OsO4 (21 µmol, 0.01 eq) and stir the reaction mixture in the dark for 2.5
hr.
17. Add 1 mL saturated aqueous sodium bisulfite to precipitate osmium salts.
18. Decant the solution and dissolve the light-brown residue in Et2O.
19. Wash the solution with saturated aqueous NaHCO3 and brine.
20. Dry the combined organic layers over Na2SO4 and concentrate under vacuum.
21. Purify the yellow residue by flash chromatography (APPENDIX 3E) using a step gradient
of 19:1 to 37:3 CH2Cl2/CH3OH to obtain S.12 (1.27 g, 90% yield).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-N4-(benzoyl)-2′-O-(ethanal)-
cytidine (S.13)
22. Dissolve the 1.27 g compound S.12 (1.91 mmol) in 20 mL of 3:1 (v/v) p-diox-
ane/water.
23. Add 0.49 g NaIO4 (2.29 mmol, 1.2 eq) and stir the reaction mixture in the dark for
4.5 hr.
24. Dilute the reaction with Et2O and wash with water.
25. Dry the organic layer over Na2SO4 and concentrate under vacuum.
26. Purify the residue by flash chromatography (APPENDIX 3E) using 19:1 (v/v)
CH2Cl2/CH3OH to obtain S.13 as a white foam (2.94 g, 97% yield).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-N4-(benzoyl)-2′-O-
(2-hydroxyethyl)cytidine (S.14)
27. Dissolve 1.17 g compound S.13 (1.85 mmol) in 19 mL CH3OH.
28. Add 21 mg NaBH4 (0.56 mmol, 0.3 eq) and stir the mixture in the dark under N2 for
90 min.
29. Dilute the solution with Et2O and wash with saturated aqueous NaHCO3 and brine.
30. Wash the aqueous layer once with Et2O.
31. Dry the combined organic layers over Na2SO4 and concentrate under vacuum.
32. Purify the residue by flash chromatography (APPENDIX 3E) using 19:1 (v/v)
CH2Cl2/CH3OH to obtain S.14 as a white foam (1.09 g, 93% yield).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-N4-(benzoyl)-2′-O-(ethyl-2-
methylsulfonate)cytidine (S.15)
33. Dissolve the 1.09 g compound S.14 (1.72 mmol) in 17 mL CH2Cl2 and 1.4 mL
pyridine (17.2 mmol, 10 eq).
34. Cool under N2 to 0°C.
35. Add 0.19 mL methanesulfonyl chloride (2.41 mmol, 1.2 eq) dropwise.
36. Stir the mixture under N2 while gradually warming to room temperature overnight.
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37. Dilute the reaction with Et2O and wash with saturated aqueous NaHCO3 and brine.
38. Dry the organic layer over Na2SO4 and concentrate under vacuum.
39. Purify the residue by flash chromatography (APPENDIX 3E) using 24:1 (v/v)
CH2Cl2/CH3OH to obtain S.15 as a white foam (1.13 g, 92% yield).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-N4-(benzoyl)-2′-O-(thioben-
zoylethyl) cytidine (S.16)
40. Dissolve 1.04 g compound S.15 (1.46 mmol) in 5.8 mL DMF.
41. Add 2.0 mL Et3N (14.6 mmol, 10 eq) and 0.34 mL thiobenzoic acid (2.91 mmol, 2.0
eq).
42. Stir the mixture under N2 in the dark overnight.
43. Dilute the solution with Et2O and wash with saturated aqueous NaHCO3 and brine.
44. Dry the organic layer over Na2SO4 and concentrate under vacuum to a dark orange-
brown solid.
45. Purify the residue by flash chromatography (APPENDIX 3E) using a step gradient of 0
to 10% CH3CN in 2:1 (v/v) petroleum ether/EtOAc to obtain S.16 as a white foam
(0.84 g, 76% yield).
Prepare N4-(benzoyl)-2′-O-(thiobenzoylethyl)cytidine (S.17)
46. Dissolve 0.37 g compound S.16 (0.49 mmol) in 4.3 mL CH3CN.
47. Add 0.5 mL of 48% aqueous HF and stir the reaction mixture for 7 hr.
48. Dilute the solution with Et2O and wash with H2O.
49. Dry the organic layer over Na2SO4 and concentrate under vacuum.
50. Purify the pink residue by flash chromatography (APPENDIX 3E) using 19:1 (v/v)
CH2Cl2/CH3OH to obtain S.17 as a white foam (0.25 g, 100% yield).
Prepare N4-(benzoyl)-2′-O-(ethyl)cytidine tert-butyl disulfide (S.18)
51. Dissolve the 0.25 g compound S.17 (0.49 mmol) in 3.8 mL of 1:1 (v/v) CH3OH/THF.
52. Add 0.20 g 1-(tert-butylthio)-1,2-hydrazinedicarboxmorpholide (Wünsch et al.,
1982) (0.58 mmol, 1.2 eq) and 41 mg LiOH⋅H2O (0.97 mmol, 2.0 eq).
53. Stir the reaction under N2 at 0°C for 45 min.
54. Dilute the reaction with EtOAc, and then wash with 1 N aqueous sodium citrate and
the saturated aqueous NaHCO3.
55. Dry the organic layer over Na2SO4 and concentrate under vacuum.
56. Purify the residue by flash chromatography (APPENDIX 3E) using 24:1 (v/v)
CH2Cl2/CH3OH to obtain S.18 as a pink foam (0.18 g, 74% yield).
Prepare 5′-O-(4,4′-dimethoxytrityl)-N4-(benzoyl)-2′-O-(ethyl)cytidine tert-butyl
disulfide (S.19)
57. Dissolve 0.10 g compound S.18 (0.21 mmol) and 13 mg DMAP (0.10 mmol, 0.5 eq)
in 0.8 mL DMF and 26 µL pyridine (0.31 mmol, 1.5 eq).
58. Add 85 mg DMTrCl (0.25 mmol, 1.2 eq) and stir the reaction under N2 for 6 hr.
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59. Dilute the reaction with CH2Cl2 and wash with saturated aqueous NaHCO3 and brine.
60. Dry the organic layer over Na2SO4 and concentrate under vacuum.
61. Purify the residue by flash chromatography (APPENDIX 3E) using 1:1 (v/v) petroleum
ether/acetone to obtain S.19 as a tan foam (0.13 g, 77% yield).
Prepare 5′-O-(4,4′-dimethoxytrityl)-N4-(benzoyl)-2′-O-(ethyl)cytidine
3′-O-(N,N-diisopropyl--cyanoethylphosphoramidite) tert-butyl disulfide (S.20)
62. Dissolve 55 mg compound S.19 (0.07 mmol) in 0.3 mL CH2Cl2 containing 60 µL
N,N-diisopropylethylamine (0.35 mmol, 5 eq).
63. Cool under N2 to 0°C.
64. Add 23 µL chloro-N,N-diisopropylamine-β-cyanoethyl phosphine (0.10 mmol, 1.5
eq) dropwise and stir the reaction under N2 while allowing it to warm to room
temperature.
65. After 2 hr, quench the excess chloridate with 0.3 mL CH3OH and concentrate the
mixture under vacuum.
66. Purify the residue by flash chromatography (APPENDIX 3E) using 2:1 (v/v) petroleum
ether/acetone to obtain S.20 as a white foam (58 mg, 84% yield).
SUPPORT
  PROTOCOL 8
SYNTHESIS OF 5′-O-(4,4′-DIMETHOXYTRITYL)-2′-O-(ETHYL)URIDINE-3′-
O-(N,N-DIISOPROPYL--CYANOETHYLPHOSPHORAMIDITE) tert-BUTYL
DISULFIDE
The intermediate S.10 prepared in Support Protocol 6 can be converted to 3′,5′-O-
(tetraisopropyldisiloxane-1,3-diyl)-2′-O-allyl uridine (S.21) using nitrobenzaldoxime
and 1,1,3,3-tetramethylguanidine as described by Sproat and Lamond (1991). The syn-
thesis of the fully protected phosphoramidites can be accomplished in nine sets of steps
(Fig. 5.4.4).
Materials
2-Nitrobenzaldoxime
1,1,3,3-Tetramethylguanidine
Acetonitrile (CH3CN)
Compound S.10 (see Support Protocol 6)
Ethyl acetate (EtOAc)
Sodium sulfate (Na2SO4)
Methanol (CH3OH)
Methylene chloride (CH2Cl2)
Acetone
N-Methylmorpholine-N-oxide
Osmium tetroxide (OsO4)
Saturated aqueous sodium bisulfite
Celite
1,4-Dioxane
Sodium periodate (NaIO4)
Diethyl ether (Et2O)
Sodium bicarbonate (NaHCO3)
Sodium borohydride (NaBH4)
Brine (saturated aqueous NaCl)
Pyridine
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Methanesulfonyl chloride
N,N-Dimethylformamide (DMF)
Triethylamine (Et3N)
Thiobenzoic acid
48% (w/v) aqueous HF
4,4′-Dimethoxytrityl chloride (DMTrCl)
4-Dimethylaminopyridine (DMAP)
Tetrahydrofuran (THF)
LiOH⋅H2O
1-(tert-Butylthio)-1,2-hydrazinedicarboxmorpholide
1 N aqueous sodium citrate
N,N-Diisopropylethylamine
Chloro-N,N-diisopropylamine-β-cyanoethyl phosphine
Petroleum ether
Additional reagents and equipment for flash chromatography (APPENDIX 3E)
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-2′-O-allyluridine (S.21)
1. Dissolve 2.1 g 2-nitrobenzaldoxime (12.3 mmol, 4 eq) and 1.4 mL 1,1,3,3-tetra-
methylguanidine (11.1 mmol, 3.6 eq) in 28 mL CH3CN.
2. Stir this solution under N2.
3. Add the solution to 2.0 g compound S.10 (3.1 mmol).
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Figure 5.4.4 Synthesis of 3′-O-(N,N-diisopropyl-β-cyanoethyl-phosphoramidite)-5′-O-(4,4′-di-
methoxytrityl)-2′-O-(ethyl)uridine tert-butyl disulfide. (a) 2-Nitrobenzaldoxime, 1,1,3,3-tetramethyl-
guanidine, CH3CN; (b) OsO4, N-methylmorpholine-N-oxide, acetone, H2O; (c) NaIO4, p-dioxane,
H2O; (d) NaBH4, CH3OH; (e) methanesulfonyl chloride, pyridine; (f) thiobenzoic acid, Et3N, DMF;
(g) HF (aq), CH3CN; (h) DMTrCl, Et3N, DMF, DMAP; (i) 1-(tert-butylthio)-1,2-hydrazine-dicar-
boxmorpholide, LiOH, CH3OH, THF; (j) chloro-N,N-diisopropylamine-β-cyanoethyl phosphine, N,N-
diisopropylethylamine, CH2Cl2. Abbreviations: Bz, benzoyl; DMAP, 4-dimethylaminopyridine; DMF,
dimethylformamide; DMTr, 4,4′-dimethoxytrityl; Ms, methanesulfonyl.
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4. Stir the reaction for 30 min at room temperature and then concentrate under vacuum.
5. Dissolve the residue in EtOAc and wash with water.
6. Backwash the water layer 3 times with EtOAc.
7. Combine the organic layers and dry over Na2SO4.
8. Concentrate under vacuum.
9. Purify the residue by flash chromatography (APPENDIX 3E) using a step gradient of 0
to 5% CH3OH in CH2Cl2 to obtain S.21 (1.61 g, 99%).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-2′-O-(2,3-dihydroxypropyl)-
uridine (S.22)
10. Dissolve 1.61 g compound S.21 (3.06 mmol) in 30 mL of 6:1 (v/v) acetone/water.
11. Add 394 mg N-methylmorpholine-N-oxide (3.4 mmol, 1.1 eq) and 7.7 mg OsO4 (0.03
mmol, 0.01 eq) and stir in the dark for 3 hr.
12. Precipitate the osmium salts with 2 mL saturated aqueous sodium bisulfite and pour
the mixture through a funnel containing Celite.
13. Evaporate the solvent under vacuum to obtain S.22 as a white foam (1.77 g, 100%
yield).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-2′-O-(ethanal)uridine (S.23)
14. Dissolve 437 mg compound S.22 (0.8 mmol) in 7.8 mL of 3:1 (v/v) 1,4-dioxane/H2O.
15. Add 209 mg NaIO4 (1.0 mmol, 1.25 eq) and stir the reaction in the dark for 6 hr.
16. Dilute the solution with Et2O and filter.
17. Wash the filtrate with saturated aqueous NaHCO3, dry over Na2SO4, and concentrate
under vacuum to obtain S.23 as a pale-yellow foam (400 mg, 97% yield).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-2′-O-(2-hydroxyethyl)uridine
(S.24)
18. Dissolve 470 mg compound S.23 (0.9 mmol) in 7.4 mL CH3OH.
It may be necessary to repeat the synthesis of S.22 to obtain the necessary quantity for the
synthesis of S.23.
19. Add 16 mg NaBH4 (0.4 mmol, 0.48 eq) and stir the mixture overnight under N2.
20. Dilute the mixture with Et2O, then wash once with saturated aqueous NaHCO3 and
twice with brine.
21. Dry the combined organic layers over Na2SO4, filter, and evaporate under vacuum to
obtain S.24 as a white foam (464 mg, 98% yield).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-2′-O-(ethyl-2-methylsulfon-
ate)uridine (S.25)
22. Dissolve 138 mg compound S.24 (0.3 mmol) in a mixture of 2.6 mL CH2Cl2 and 0.21
mL pyridine.
23. Cool to 0°C.
24. Add 28 µL methanesulfonyl chloride (0.4 mmol, 14 eq) dropwise while stirring under
N2.
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25. Allow the reaction to warm to room temperature over 18 hr.
26. Dilute the mixture with CH2Cl2 and wash once with saturated aqueous NaHCO3.
27. Dry the organic layer over Na2SO4, filter, and evaporate under vacuum.
28. Purify the residue by flash chromatography (APPENDIX 3E) using 17:3 (v/v)
CH2Cl2/acetone to obtain S.25 as a white foam (133 mg, 84% yield).
Prepare 3′,5′-O-(tetraisopropyldisiloxane-1,3-diyl)-2′-O-(thiobenzoylethyl)uridine
(S.26)
29. Dissolve 552 mg compound S.25 (0.9 mmol) in a mixture of 3.6 mL DMF and 1.3
mL Et3N (9.1 mmol, 10.0 eq).
It may be necessary to repeat the synthesis of S.25 to obtain the necessary quantity for the
synthesis of S.26.
30. Add 0.21 mL thiobenzoic acid (1.8 mmol, 2 eq) and stir overnight under N2.
31. Dilute the mixture with Et2O, then wash once with saturated aqueous NaHCO3 and
twice with brine.
32. Dry the combined organic extracts over Na2SO4, filter, and concentrate under vac-
uum.
34. Purify the residue by flash chromatography (APPENDIX 3E) using a step gradient of 47:3
to 4:1 (v/v) CH2Cl2/acetone to obtain S.26 as a white foam (472 mg, 80% yield).
Prepare 2′-O-(thiobenzoylethyl)uridine (S.27)
35. Dissolve the 472 mg compound S.26 (0.7 mmol) in 5.8 mL CH3CN.
36. Add 1.3 mL of 48% aqueous HF and stir for 4 hr.
37. Dilute the mixture with EtOAc and wash once with H2O.
38. Dry the organic layer over Na2SO4 and filter.
39. Evaporate under vacuum to obtain S.27 as a white foam (327 mg, 100% yield).
Prepare 5′-O-(4,4′-dimethoxytrityl)-2′-O-(thiobenzoylethyl)uridine (S.28)
40. Dissolve 277 mg compound S.27 (0.7 mmol) in 2.7 mL DMF and 82 µL pyridine
(1.0 mmol, 1.5 eq).
41. Add 280 mg DMTrCl (0.8 mmol, 1.2 eq) and 54 mg DMAP (0.4 mmol, 0.65 eq).
42. Stir the reaction overnight under N2.
43. Dilute the reaction with CH2Cl2 and wash the solution once with saturated aqueous
NaHCO3 and twice with brine.
44. Dry the combined organic extracts over Na2SO4, filter, and concentrate under vac-
uum.
45. Purify the residue by flash chromatography (APPENDIX 3E) using 48:1 (v/v)
CH2Cl2/CH3OH) to obtain S.28 as a yellow foam (302 mg, 63% yield).
Prepare 5′-O-(4,4′-dimethoxytrityl)-2′-O-(ethyl)uridine tert-butyl disulfide (S.29)
46. Dissolve 293 mg compound S.28 (0.4 mmol) in 3.3 mL of 1:1 (v/v) THF/CH3OH.
47. Add 26 mg LiOH⋅H2O (0.6 mmol, 1.5 eq).
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48. After stirring for 2 min, add 164 mg 1-(tert-butylthio)-1,2-hydrazinedicarboxmor-
pholide (0.5 mmol, 1.2 eq) (Wünsch et al., 1982).
49. Stir the mixture for an additional 10 min under N2.
50. Dilute the solution with CH2Cl2.
51. Wash the solution with 1 N aqueous sodium citrate, saturated aqueous NaHCO3, and
brine.
52. Dry the organic layer over Na2SO4.
53. Filter the solution and evaporate under vacuum.
54. Purify the residue by flash chromatography (APPENDIX 3E) using 49:1 (v/v)
CH2Cl2/CH3OH to obtain S.29 as a white foam (285 mg, 100% yield).
Prepare 3′-O-(N,N-diisopropyl--cyanoethyl-phosphoramidite)-5′-O-(4,4′-
dimethoxytrityl)-2′-O-(ethyl)uridine tert-butyl disulfide (S.30)
55. Dissolve 49 mg compound S.29 (0.07 mmol) in 0.28 mL CH2Cl2 containing 62 µL
N,N-diisopropylethylamine (0.4 mmol, 5 eq) and cool to 0°C.
56. Add 24 µL chloro-N,N-diisopropylamine-β-cyanoethyl phosphine (0.1 mmol, 1.5 eq)
dropwise.
57. Stir the mixture for 2 hr under N2.
58. Dilute the solution with CH3OH.
59. Concentrate the solution under vacuum.
60. Purify the residue by flash chromatography (APPENDIX 3E) using 19:6 (v/v) petroleum
ether/acetone to obtain S.30 as a white foam (49 mg, 78% yield).
REAGENTS AND SOLUTIONS
Use deionized, distilled water in all recipes and protocol steps. For common stock solutions, see
APPENDIX 2A; for suppliers, see SUPPLIERS APPENDIX.
CPM buffer, 5×
7.6 g Tris⋅Cl (250 mM)
38 g NaCl (2.6 mM)
46.5 mg Na2EDTA (0.5 mM)
0.38 mL Triton X-100 (0.15%, v/v)
H2O to 200 mL
Adjust pH to 7.5 with 1 N NaOH or HCl
Add H2O to 250 mL
Store up to 1 month at 25°C
CPM in isopropanol, 0.4 mM
Dissolve 1.6 mg of 7-diethylamino-3-(4′-maleimidylphenyl)-4-methylcoumarin
(Molecular Probes) in 10 mL HPLC-grade isopropanol. Store up to 1 week at 25°C.
Denaturing polyacrylamide gel solution, 8%
0.32 g bisacrylamide
9.28 g acrylamide
57.7 g urea (8 M final)
24 mL 5× TBE buffer (APPENDIX 2A)
H2O to 120 mL
Prepare fresh daily
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MgCl2, 200 mM
Dissolve 10.2 g magnesium chloride hexahydrate in 250 mL water. Store at room
temperature (stable for several months).
Sodium acetate, 1.5 M, pH 5.5
Dissolve 12.3 g anhydrous sodium acetate (NaOAc) in 100 mL water. Adjust pH to
5.5 with glacial acetic acid. Store up to 6 months at 25°C.
Sodium phosphate buffer, 100 mM, pH 8.3
17.8 g Na2HPO4
H2O to 900 mL
Adjust pH to 8.3 with 1 N H3PO4 or NaOH
Add H2O to 1 L
Store up to 6 months at 25°C
Sodium phosphate buffer/NaCl, pH 7.0
100 mM sodium phosphate buffer, pH 7.0 (APPENDIX 2A)
5 mM NaCl (APPENDIX 2A)
Check pH and adjust to 7.0 with 1 N H3PO4 or NaOH, if necessary
Store up to 6 months at 25°C
COMMENTARY
Background Information
Generation of cysteine mutants in proteins
capable of forming disulfide bonds is a useful
technique to stabilize structure as well as to
probe structure, folding, and dynamics. Disul-
fide cross-links have also been incorporated
into DNA to examine ground-state structure,
trap non-ground-state structures, and examine
protein-DNA and DNA-DNA interactions
(Glick, 1998). Disulfide cross-links have more
recently been incorporated into RNA se-
quences to stabilize secondary structure (Good-
win and Glick, 1994; Allerson and Verdine,
1995), to examine dynamic motion between
helices in the Tetrahymena ribozyme (Cohen
and Cech, 1997), and to probe solution confor-
mation of a tRNA, the hammerhead ribozyme,
and the hairpin ribozyme (Sigurdsson et al.,
1995; Goodwin et al., 1996; Earnshaw et al.,
1997; Maglott and Glick, 1998).
The methods that have been used to incor-
porate disulfide bonds into RNA have relied
on either air oxidation or thiol-disulfide ex-
change. Although air oxidation is slower than
thiol-disulfide exchange, using the method-
ology presented here it is possible to achieve
quantitative conversion of the purified thiol-
modified RNA to disulfide-cross-linked
RNA. The ability to form intramolecular di-
sulfide cross-links in quantitative yields
makes it possible to produce milligram quan-
tities of these constructs, which can then be
used in a wide variety of biophysical and
biochemical experiments. In addition, attach-
ment of the alkylthiol tethers at positions other
than the 5′ or 3′ hydroxyls allows for radiola-
beling of constructs modified at the termini
of the RNA.
Disulfide cross-links can be incorporated
into RNA secondary and tertiary structures at
many different locations. The specific thiol-
modified nucleosides that are needed to create
a particular cross-link depend on the location
of the cross-links within the RNA. It is possible
to form cross-links between two of the same
thiol-modified nucleosides or between two dif-
ferent thiol-modified nucleosides. The prepa-
ration of nucleosides with thiol modifications
at the N3 position of uridine as well as at the 2′
hydroxyl of both cytidine and uridine is de-
scribed in this unit. Preparation of many other
thiol-modified nucleosides has been reported,
including those with alkylthiols on both G and
A (Glick, 1998). Use of particular bases de-
pends on the specific application (see Glick,
1998). The thiol group in each of these nucleo-
sides is protected as a tert-butyl disulfide,
which is stable to all conditions of solid-phase
synthesis. These protocols involve relatively
simple synthetic organic chemistry techniques
and standard glassware and equipment. In ad-
dition to the thiol-modified nucleosides de-
scribed here, synthesis of both adenosine and
guanosine derivatized with 2′-O-alkyl linkers
has been achieved (Manoharan et al., 1993;
Douglas et al., 1994; Gundlach et al., 1997).
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Alkylthiol-modified nucleosides have also
been described with linkers at, among others,
the C5 position of pyrimidines (Sun et al.,
1996), the C8 position of purines (Gundlach et
al., 1997), and all exocyclic amine groups on
both purines and pyrimidines (Allerson et al.,
1997).
Compound Characterization
N3-(2-Thiobenzoylethyl)uridine (S.1). TLC
(9:1 CH2Cl2/CH3OH) Rf = 0.41. 1H NMR (300
MHz, CD3CN) δ 3.30 (2 H, t, J = 5 Hz,
CH2SC(O)Ar), 3.65-3.81 (2H, 2 dd, J = 2.5, 10
Hz, 5′, 5′′), 3.96 (1H, m, 4′), 4.16-4.19 (4H, m,
2′, 3′, NCH2), 5.66 (1H, d, J = 8.1 Hz, 6), 5.80
(1H, d, J = 3.8 Hz, 1′), 7.43-7.62 (3H, m, Ar),
7.81 (1H, d, J = 8.1 Hz, 5), 7.88 (2H, d, J = 7.3
Hz, Ar). 13C NMR (75 MHz, CD3CN) δ 27.4
(CH2SC(O)Ar), 40.9 (NCH2), 62.1 (5′), 70.8
(3′), 75.6 (2′), 85.9 (4′), 91.8 (1′), 102.1 (5),
128.0, 129.9, 134.7, 138.0 (Ar), 140.3 (6),
152.4 (2), 163.9 (4), 192.4 (SC(O)Ar). IR
(KBr) ν 3548, 3448, 3086, 3060, 2944, 2901,
1706, 1673, 1655, 1462, 1388, 1286, 1211,
1124, 1079, 919, 813, 779, 695, 647, 569 cm−1.
MS (FAB, 3-NBA/trifluoroacetic acid) m/z 409
(M+ + 1).
5′-O-(4,4′-Dimethoxytrityl)-N3-(ethyl)uridine
tert-butyl disulfide (S.2). 1H NMR (360 MHz,
CD3CN) δ 1.31 (9H, s, SS(CH3)3), 2.90 (2H,
t, J = 6.0 Hz, CH2SS), 3.36 (2H, m, 5′,5′′), 3.75
(6H, s, 2 OCH3), 4.02 (1H, m, 4′), 4.11 (2H,
m, NCH2), 4.18 (1H, m, 2′), 4.32 (1H, m, 3′),
5.38 (1H, d, J = 8.1 Hz, 6), 5.78 (1H, d, J = 3.2
Hz, 1′), 6.85-7.44 (13H, m, Ar), 7.73 (1H, d, J
= 8.1 Hz, 5). 13C NMR (90 MHz, CD3CN) δ
30.1 (SSC(CH3)3) ,  37.2 (CH2SS), 41.0
(NCH2), 48.5 (SSC(CH3)3), 56.0 (OCH3), 63.4
(5′), 70.5 (3′), 75.5 (2′), 83.8 (4′), 87.5
(OC(Ph)3), 91.4 (1′), 101.9 (5), 114.2 (Ar),
128.0, 129.0, 131.1, 136.5, 136.7 (Ar), 139.7
(6), 145.9 (Ar), 152.0 (2), 159.8 (Ar), 163.3
(4). IR (film; NaCl) ν 3452, 2959, 2940, 1708,
1665, 1608, 1509, 1457, 1252, 1177, 1103,
1035, 829, 810, 702 cm−1. MS (FAB, 3-NBA)
m/z 695 (M+ + 1).
5′-O-(4,4′-Dimethoxytrityl)-2′-O-(tert-butyl-
dimethylsilyl)-N3-(ethyl)uridine tert-butyl di-
sulfide (S.3) TLC (4:1 petroleum ether/EtOAc)
Rf = 0.30. 1H NMR (300 MHz, CD3CN) δ 0.12
(6H, s, Si(CH3)2), 0.90 (9H, s, SiC(CH3)3), 1.30
(9H, s, SSC(CH3)3), 2.88 (2H, t, J = 8.0 Hz,
CH2HS), 3.38 (2H, 2 dd, J = 2.4, 11.0 Hz,
5′,5′′), 3.74 (6H, s, 2 OCH3), 4.05 (3H, m, 4′,
NCH2), 4.24 (1H, m, 2′), 4.31 (1H, m, 3′), 5.35
(1H, d, J = 8.2 Hz, 6), 5.83 (1H, d, J = 4.0 Hz,
1′), 6.84-7.43 (13H, m, Ar), 7.74 (1H, d, J = 8.1
Hz, 5). 13C NMR (75 MHz, CD3CN) δ –4.4
(Si(CH3)2),  18.8 (SiC(CH3)3) ,  26.3
(SiC(CH3)3) ,  30.2 (SSC(CH3)3) ,  37.5
(CH2SS), 41.0 (NCH2), 48.4 (SSC(CH3)3),
55.9 (OCH3), 63.7 (5′), 71.2 (3′), 76.9 (2′), 84.1
(4′), 87.7 (OC(Ph)3), 90.6 (1′), 102.1 (5), 114.1
(Ar), 127.8, 128.8, 128.9, 130.9, 136.3, 136.5
(Ar), 139.3 (6), 145.6 (Ar), 151.7 (2), 159.7
(Ar), 162.8 (4). IR (film; NaCl) ν 3856, 3546,
2955, 2930, 2857, 2361, 2334, 1710, 1668,
1608, 1509, 1456, 1253, 1177, 1122, 1036, 836
cm−1. MS (FAB, 3-NBA) m/z 809 (M+ + 1).
5′-O-(4,4′-Dimethoxytrityl)-3′-O-(tert-butyl-
dimethylsilyl)-N3-(ethyl)uridine tert-butyl di-
sulfide (S.4) TLC (4:1 petroleum ether/EtOAc)
Rf = 0.14. 1H NMR (300 MHz, CD3CN) δ 0.04,
0.05 (6H, 2 s, Si(CH3)2), 0.81 (9H, s,
SiC(CH3)3), 1.30 (9H, s, SSC(CH3)3), 2.88
(1H, dd, J = 3.8, 11.1 Hz, 5′), 2.89 (2H, t, J =
7.6 Hz, CH2SS), 3.46 (1H, dd, J = 2.4, 11.0 Hz,
5′′), 3.74 (6H, s, 2 OCH3), 4.00 (1H, m, 4′),
4.10 (3H, m, 2′, NCH2), 4.33 (1H, m, 3′), 5.38
(1H, d, J = 8.1 Hz, 6), 5.80 (1H, d, J = 3.0 Hz,
1′), 6.84-7.42 (13H, m, Ar), 7.74 (1H, d, J = 8.1
Hz, 5). 13C NMR (75 MHz, CD3CN) δ –4.4,
–4.1 (Si(CH3)2) ,  18.7 (SiC(CH3)3), 26.3
(SiC(CH3)3) ,  30.3 (SSC(CH3)3) ,  37.5
(CH2SS), 41.0 (NCH2), 48.3 (SSC(CH3)3, 56.0
(OCH3), 63.3 (5′), 72.0 (3′), 75.4 (2′), 84.1 (4′),
87.7 (OC(Ph)3), 92.0 (1′), 102.1 (5), 114.1 (Ar),
127.7, 128.7, 129.0, 131.0, 136.4 (Ar), 139.6
(6), 145.5 (Ar), 151.7 (2), 159.7 (Ar), 162.9 (4).
IR (film; NaCl) ν 3869, 2955, 2929, 2858,
2364, 2334, 1710, 1670, 1509, 1456, 1252,
1176, 1116, 1035, 836 cm−1. MS (FAB, 3-
NBA) m/z 809 (M+ + 1).
5′-O-(4,4′-Dimethoxytrityl)-2′-O-(tert-butyl-
dimethylsilyl)-N3-(ethyl)uridine-3′-O-(N,N-di-
isopropyl-β-cyanoethylphosphoramidite) tert-
butyl disulfide (S.5). TLC (80:15:5 petroleum
ether/EtOAc/Et3N) Rf = 0.28. 1H NMR (300
MHz, CD3CN) δ (two diastereomers) 0.09,
0.12 (6H, 2 s, Si(CH3)2), 0.83, 0.85 (9H, 2 s,
SiC(CH3)3), 1.01, 1.14 (12H, d, J = 9 Hz, 2
NCH(CH3)2), 1.31 (9H, s, SSC(CH3)3), 2.45
(2H, m, OCH2CH2CN), 2.88 (2H, m, CH2SS),
3.40 (2H, m, 5′,  5′′), 3.50-3.90 (4H, m,
OCH2CH2CN, 2 NCH(CH3)2), 3.75 (6H, s, 2
OCH3), 4.10 (2H, m, NCH2CH2SS), 4.20-4.42
(3H, m, 2′, 3′, 4′), 5.37, 5.39 (1H, d, J = 8.1 Hz,
6), 5.84, 5.89 (1H, d, J = 6.6 Hz, 1′), 6.83-7.46
(13H, m, Ar), 7.72, 7.77 (1H, d, J = 8.1 Hz, 5).
13C NMR (75 MHz, CD3CN) δ (two dias-
tereomers) –4.2 (Si(CH3)2), 18.9 (SiC(CH3)3),
21.1 (OCH2CH2CN), 25.0, 25.1, 25.2, 25.3
(NCH(CH3)2),  26.4 (SiC(CH3)3),  30.4
(SC(CH3)3) ,  37.8 (CH2SS), 41.2 (NCH2
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CH2SS), 44.1, 44.3, 44.5, 44.6 (NCH(CH3)2),
48.5 (SSC(CH3)3), 56.2 (OCH3), 59.4, 60.0
(POCH2CH2CN), 64.0, 64.2 (5′), 73.5, 73.7
(3′), 76.1, 76.5 (2′), 83.9, 84.0 (4′), 88.1
(OC(Ph)3), 90.3, 90.4 (1′), 102.4, 102.5 (5),
114.4 (Ar), 128.1, 129.0, 129.2, 129.3, 131.2,
136.4, 136.5, 136.6 (Ar), 139.3, 139.4 (6),
145.7, 145.8 (Ar), 152.1 (2), 160.0 (Ar), 162.9,
163.0 (4). 31P NMR (202 MHz, CD3CN) δ (two
diastereomers) 147.4, 146.8. IR (KBr) ν 2965,
2931, 2859, 2254, 1712, 1671, 1611, 1509,
1456, 1391, 1365, 1253, 1179, 1037, 979, 836
cm−1. MS (FAB, 3-NBA) m/z 1009.5 (M+ + 1).
Anal. Calcd for C51H73N4O9PS2Si: C, 60.70;
H, 7.28; N, 5.55. Found: C, 60.77; H, 7.24; N,
5.47.
5′-O-(4,4′-Dimethoxytrityl)-3′-O-(tert-butyl-
dimethylsilyl)-2′-O-pentachlorophenylsuccinate
N3-(ethyl)uridine tert-butyl disulfide (S.6). TLC
(4:1 petroleum ether/EtOAc) Rf = 0.68. 1H
NMR (360 MHz, CD3CN) δ –0.07, 0.01 (6H,
s, Si(CH3)2), 0.79 (9H, s, SiC(CH3)3), 1.29 (9H,
s, SSC(CH3)3), 2.79 (4H, m, succinate CH2),
3.03 (2H, m, CH2SS), 3.29-3.47 (2H, m, 5′, 5′′),
3.76 (6H, s, 2 OCH3), 3.96-4.12 (3H, m, 4′,
NCH2), 4.38 (1H, m, 3′), 5.43 (2H, m, 6, 2′),
5.97 (1H, d, J = 4.8 Hz, 1′), 6.21-7.45 (13H, m,
Ar), 7.65 (1H, d, J = 8.1 Hz, 5). 13C NMR (90
MHz, CD3CN) δ –4.4, –4.1 (Si(CH3)2), 18.6
(SiC(CH3)3), 26.1 (SiC(CH3)3), 29.4, 29.5
(succinate CH2), 30.2 (SSC(CH3)3), 37.0
(CH2SS), 41.1 (NCH2CH2SS), 48.5
(SSC(CH3)3), 56.0 (OCH3), 63.6 (5′), 71.4 (3′),
76.1 (2′), 85.3 (4′), 88.0 (OC(Ph)3), 88.7 (1′),
102.5 (5), 114.2 (Ar), 128.1, 129.0, 129.1,
131.2, 136.4 (Ar), 139.4 (6), 145.7 (Ar), 152.0
(2), 159.9 (Ar), 163.1 (4), 169.6, 171.8 (succi-
nate CO2). IR (film; NaCl) ν 2956, 2931, 1786,
1751, 1713, 1672, 1608, 1509, 1455, 1390,
1363, 1253, 1229, 1177, 1154, 1107, 1036, 837
cm−1. MS (FAB, 3-NBA) m/z 1173 (M+ + 1).
Anal. Calcd for C52H59N2O11S2SiCl5: C, 53.96;
H, 5.10; N, 2.42. Found C, 54.03; H, 5.15; N,
2.40.
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
uridine (S.8). TLC (1:1 petroleum ether/
EtOAc) Rf 0.28; 1H NMR (300 MHz, CDCl3)
δ 1.03-1.11 (28H, m, isopropyl), 3.56-4.40
(5H, m, 2′,3′,4′,5′,5′′), 5.70 (1H, dd, 5), 5.74
(1H, s, 1′), 7.71 (1H, d, 6), 8.83 (1H, s, NH);
13C NMR (90 MHz, CDCl3) δ 12.63-13.55
(isopropyl CHs), 16.98-17.65 (isopropyl
CH3s), 60.29 (5′), 68.85 (3′), 75.32 (2′), 82.05
(4′), 91.15 (1′), 102.18 (5), 140.10 (6), 150.48
(2), 163.84 (4); IR (KBr pellet) ν 3434, 3200,
3063, 2946, 2868, 1703, 1465, 1388, 1270,
1211, 1123, 1091, 1060, 1038, 993, 907, 885,
861, 809, 774, 705, 553 cm−1; MS (CI, CH4)
m/z 487 (MH+).
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
O4-(2-nitrophenyl) uridine (S.9). TLC (1:1 pe-
troleum ether/EtOAc) Rf 0.27; 1H NMR (300
MHz, CDCl3) δ 1.00-1.11 (28H, m, isopropyl),
3.99-4.37 (5H, m, 2′,3′,4′,5′,5′′), 5.74 (1H, s,
1′), 6.21 (1H, d, 5), 7.32 (1H, d, Ar), 7.41 (1H,
ddd, Ar), 7.67 (1H, ddd, Ar), 8.13 (1H, dd, Ar),
8.23 (1H, d, 6); 13C NMR (75 MHz, CDCl3) δ
12.89-13.70 (isopropyl CHs), 17.14-17.71
(isopropyl CH3s), 60.71 (5′), 69.28 (3′), 75.29
(2′), 82.34 (4′), 92.46 (1′), 94.78 (5), 125.76,
126.14, 126.81, 134.88, 141.90, 145.08 (Ar),
145.19 (6), 154.68 (2), 171.10 (4).
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
2′-O-allyl-O4-(2-nitrophenyl) uridine (S.10).
TLC (1:1 petroleum ether/EtOAc) Rf 0.68. 1H
NMR (300 MHz, CDCl3) δ 1.00-1.12 (28H, m,
isopropyl), 3.93-4.44 (7H, m, 2′,3,4′,5′,5′′, allyl
CH2), 5.16 (1H, ddd, =CH2a), 5.39 (1H, m,
=CH2b), 5.76 (1H, s, 1′), 5.92 (1H, m, CH=),
6.19 (1H, d, 5), 7.33 (1H, dd,Ar), 7.41 (1H, ddd,
Ar), 7.67 (1H, ddd, Ar), 8.13 (1H, dd, Ar), 8.38
(1H, d, 6); 13C NMR (75 MHz, CDCl3) δ
12.92-13.79 (isopropyl CHs), 17.16-17.79
(isopropyl CH3s), 59.85 (5′), 68.04 (3′), 71.51
(OCH2), 81.02 (2′), 82.16 (4′), 90.46 (1′), 94.50
(5), 117.29 (=CH2), 125.80, 126.13, 126.76,
134.73 (Ar), 134.82 (CH=), 142.00 (Ar),
144.77 (6), 145.26 (Ar) 154.72 (2), 171.06 (4);
IR (KBr pellet) ν 3105, 2947, 2869, 1683, 1633,
1603,1549, 1531, 1454, 1365, 1351, 1288,
1220, 1166, 1126, 1073, 1041, 1014, 991, 886,
858, 780, 698 cm−1; MS (CI, CH4) m/z 648
(M+).
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
N4-(benzoyl)-2′-O-allyl cytidine (S.11). TLC
(2:3 EtOAc/petroleum ether) Rf = 0.32. 1H
NMR (300 MHz, CDCl3) δ 0.96-1.11 (28H, m,
4 (CH3)2HSi, 4 (CH3)2HSi), 3.95-4.02 (2H, m,
2′-H, 5′-Ha), 4.16 (1H, dd, J = 4.1, 9.6 Hz, 3′-H),
4.24-4.32 (2H, m, 4′-H, 5′-Hb), 4.39-4.52 (2H,
m, 7-Ha,b), 5.19 (1H, d, J = 10.5 Hz, 9-Htrans),
5.42 (1H, d, J = 16.0 Hz, 9-Hcis), 5.84 (1H, s,
1′-H), 5.87-6.00 (1H, m, 8-H), 7.47-7.62 (4H,
m, 5-H, ArH), 7.90-7.92 (2H, m, ArH), 8.39
(1H, d, J = 7.5 Hz, 6-H). 13C NMR (75 MHz,
CDCl3) δ 12.6, 13.0, 13.2, 13.5 ((CH3)2)CHSi),
16.9, 17.0, 17.1, 17.4, 17.5 ((CH3)2)CHSi),
59.5 (5′), 67.8 (3′), 71.3 (7), 80.8 (2′), 81.9 (4′),
90.1 (1′), 96.1 (5), 117.2 (9), 127.5, 128.9 (Ar.),
133.0 (8, Ar.), 134.4 (6), 144.4 (2), 162.2 (4).
IR (film; NaCl) ν 2946, 2868, 1699, 1667,
1620, 1553, 1488, 1264, 1126, 1040, 886 cm−1.
FAB MS (3-NBA) m/z 630 (M+ + 1).
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3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
2′-O-(2,3-dihydroxypropyl)cytidine (S.12).
TLC (19:1 CH2Cl2/CH3OH) Rf = 0.23; 1H
NMR (360 MHz, CDCl3) δ (two diastereom-
ers) 0.98-1.11 (28H, m, 4 (CH3)2)CHSi, 4
(CH3)2)CHSi), 3.66 (1H, dd, J = 5.2, 10.7 Hz,
CH(OH)CH2aOH), 3.72-3.76 (2H, m,
CH2CH(OH)CH2, CH(OH)CH2bOH), 3.88-
4.06 (4H, m, 2′, 5′, OCH2CH(OH)), 4.15-4.28
(2H, m, 3′, 4′), 4.30 (1H, d, J = 13.5 Hz, 5′′),
5.83 (1H, s, 1′), 7.49-7.63 (4H, m, 5, Ar),
7.90-7.92 (2H, m, Ar), 8.31-8.34 (1H, m, 6),
8.94 (1H, br s, NH). 13C NMR (90 MHz,
CDCl3) δ (two diastereomers) 12.5, 12.6,
12.9, 13.0 ((CH3)2CHSi), 16.8, 16.9, 17.0,
17.3, 17.4, 17.4, 17.6 ((CH2CHSi), 59.2
(5′), 63.6, 63.9 (CH(OH)CH2OH), 67.8 (3′),
70.4, 70.5 (OCH2CH(OH)), 73.4, 74.3
(CH3)2CH(OH)CH2), 82.0 (2′), 83.1, 83.3
(4′), 89.9, 90.2 (1′), 96.3 (5), 127.6, 129.0,
132.8 (Ar), 133.3 (6), 144.3 (2), 162.5 (4).
IR (film; NaCl) ν 3367, 2946, 2868, 1700,
1655, 1617, 1486, 1257, 1126, 1040, 886,
704 cm−1. MS (FAB, 3-NBA) m/z 664 (M+
+ 1).
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
N4-(benzoyl)-2′-O-(ethanal)cytidine (S.13). TLC
(37:3 CH2Cl2/CH3OH) Rf = 0.50; 1H NMR
(360 MHz, CDCl3) δ 0.98-1.11 (28H, m, 4
(CH3)2CHSi, 4 (CH3)2CHSi), 3.98-4.07 (2H,
m, 2′, 5′), 4.18-4.31 (3H, m, 3′, 4′ ,5′′), 4.47-
4.59 (2H, m, OCH2CHO), 5.86 (1H, s, 1′),
7.49-7.63 (4H, m, 5, Ar), 7.89-7.91 (2H, m, Ar),
8.37 (1H, d, J = 7.5 Hz, 6), 8.81 (1H, br s, NH),
9.81 (1H, s, CH2CHO). 13C NMR (90 MHz,
CDCl3) δ 12.3, 12.9, 13.0, 13.4 ((CH3)2CHSi),
16.7, 16.9, 17.3, 17.4 ((CH3)2CHSi), 59.2 (5′),
68.1 (3′), 76.2 (OCH2CHO), 81.8 (2′), 83.0 (4′),
89.7 (1′), 96.2 (5), 127.5, 129.0, 132.8 (Ar),
133.2 (6), 144.3 (2), 162.4 (4), 200.7
(CH2CHO). IR (film; NaCl) ν 2946, 2868,
1700, 1667, 1619, 1484, 1253, 1130, 1064,
1040, 886, 703 cm−1. MS (FAB, 3-NBA) m/z
632 (M+ + 1).
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
N4-(benzoyl)-2′-O-(2-hydroxyethyl)cytidine
(S.14). TLC (37:3 CH2Cl2/CH3OH) Rf = 0.56.
1HNMR (360 MHz, CDCl3) δ 0.99-1.10 (28H,
m, 4 (CH3)2CHSi, 4 (CH3)2CHSi), 3.17 (1H,
br s ,  CH2CH2OH),  3.72-3.77 (2H, m,
CH2CH2OH),  3.93-4.03 (4H, m, 2′,  5′,
OCH2CH2OH), 4.15-4.25 (2H, m, 3′, 4′), 4.30
(1H, d, J = 13.6 Hz, 5′′), 5.83 (1H, s, 1′),
7.49-7.63 (4H, m, 5, Ar), 7.89-7.92 (2H, m,
Ar), 8.35 (1H, d, J = 7.5 Hz, 6), 8.92 (1H, br
s, NH). 13C NMR (90 MHz, CDCl3) δ 12.6,
12.9, 13.0, 13.4 ((CH3)2CHSi), 16.8, 16.9,
17.0, 17.3, 17.4, 17.4 ((CH3)2CHSi), 59.3 (5′),
61.7 (CH2CH2OH), 68.0 (3′) ,  73.1
(OCH2CH2OH), 82.0 (2′), 82.3 (4′), 90.5 (1′),
96.2 (5), 127.5, 129.0, 132.9 (Ar), 133.2 (6),
144.3 (2), 162.4 (4). IR (film; NaCl) ν 2946,
2868, 1699, 1664, 1619, 1485, 1263, 1128,
1074, 1063, 1040, 886, 703 cm−1. MS (FAB,
3-NBA) m/z 634 (M+ + 1).
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
N4-(benzoyl)-2′-O-(ethyl-2-methylsul- fon-
ate)cytidine (S.15) .  TLC (19:1 CH2Cl2/
CH3OH) Rf = 0.35. 1H NMR (360 MHz,
CDCl3) δ 0.97-1.11 (28H, m, 4 (CH3)2CHSi, 4
(CH3)2CHSi), 3.14 (3H, s, CH3SO2), 3.97-4.01
(2H, m, 2′, 5′), 4.17-4.21 (4H, m, 3′, 4′,
OCH2HH2OSO2), 4.30 (1H, d, J = 13.7 Hz, 5′′),
4.46-4.49 (2H, m, CH2CH2OSO2), 5.82 (1H, s,
1′), 7.50-7.62 (4H, m, 5, Ar), 7.89-7.92 (2H, m,
Ar), 8.38 (1H, d, J = 7.5 Hz, 6). 13C NMR (90
MHz, CDCl3) δ 12.4, 12.9, 13.1, 13.4
((CH3)2CHSi), 16.8, 16.9, 17.1, 17.3, 17.4,
17.4 ((CH3)2CHSi), 37.80 (CH3SO2), 59.3 (5′),
67.9 (3′), 69.0 (CH2CH2OSO2), 69.5 (OCH2
CH2OSO2), 81.9 (2′), 82.4 (4′), 89.5 (1′), 96.2
(5), 127.6, 129.1, 132.8 (Ar), 133.3 (6), 144.5
(2), 162.4 (4). IR (film; NaCl) ν 2945, 2868,
1664, 1484, 1170, 1128, 1074, 1063, 1040,
885, 704 cm−1 MS (FAB, 3-NBA) m/z 712 (M+
+ 1).
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
N4-(benzoyl)-2′-O-(thiobenzoylethyl)
cytidine (S.16).  TLC (6:3:1 petroleum
ether/EtOAc/CH3CN) Rf = 0.57. 1H NMR (360
MHz, CDCl3) δ 0.98-1.11 (28H, m, 4
(CH3)2CHSi, 4 (CH3)2CHSi), 3.35-3.43 (2H,
m, CH2CH2SBz), 3.97-4.02 (2H, m, 2′, 5′),
4.09-4.13 (2H, m, OCH2CH2SBz), 4.18 (1H,
dd, J = 3.9, 9.6 Hz, 3′), 4.25 (1H, dd, J = 2.0,
9.6 Hz, 4′), 4.30 (1H, d, J = 13.5 Hz, 5′′), 5.84
(1H, s, 1′), 7.40-7.62 (7H, m, 5, Ar), 7.91-7.99
(4H, m, Ar), 8.37 (1H, d, J = 7.4 Hz, 6), 8.97
(1H, br s, NH). 13C NMR (90 MHz, CDCl3) δ
12.5, 12.8, 13.1, 13.4 ((CH3)2CHSi), 16.8,
16.9, 17.1, 17.3, 17.4, 17.5 ((CH3)2CHSi), 29.1
(CH2CH2SBz), 59.4 (5′), 67.9 (3′), 69.9
(OCH2CH2SBz), 81.8 (2′), 81.9 (4′), 90.0 (1′),
96.0 (5), 127.2, 127.6, 128.5, 129.0, 133.0 (Ar),
133.2 (6), 137.1 (Ar), 144.6 (2), 162.3 (4),
191.5 (Ar). IR (film; NaCl) ν 2945, 2868, 1699,
1667, 1620, 1489, 1373, 1265, 1126, 1075,
1063, 1040, 691 cm−1. EI MS m/z 754 (M+ +
1).
N4-(Benzoyl)-2′-O-(thiobenzoylethyl)cytidine
(S.17). TLC (19:1 CH2Cl2/CH3OH) Rf = 0.21.
1H NMR (360 MHz, CDCl3) δ 3.25-3.42 (2H,
m, CH2SBz), 3.91-3.96 (2H, m, 2′, 5′), 4.05-
4.19 (3H, m, 5′′, OCH2CH2SBz), 4.20-4.25
Current Protocols in Nucleic Acid Chemistry
5.4.29
Methods for
Cross-Linking
Nucleic Acids
(1H, m, 4′), 4.35-4.37 (1H, m, 3′), 5.87 (1H, s,
1′), 7.33-7.54 (7H, m, 5, Ar), 7.82-7.94 (4H, m,
Ar), 8.57 (1H, d, J = 7.5 Hz, 6), 9.22 (1H, br s,
NH). 13C NMR (90 MHz, CDCl3) δ 28.8
(CH2SBz), 59.8 (5′) ,  67.4 (3′),  69.4
(OCH2CH2SBz), 82.0 (2′), 84.6 (4′), 90.1 (1′),
96.7 (5), 126.8, 127.2, 127.6, 128.3, 128.6,
128.8, 132.9, 133.1 (Ar), 133.5 (6), 136.7 (Ar),
146.0 (2), 162.6 (4), 191.4 (Ar). IR (film; NaCl)
ν 3345, 2928, 1699, 1658, 1617, 1558, 1485,
1379, 1258, 1111, 1067, 913, 705, 689 cm−1.
MS (FAB, 3-NBA) m/z 512 (M+ + 1).
N4-(Benzoyl)-2′-O-(ethyl)cytidine tert-bu-
tyl disulfide (S.18). TLC (24:1 CH2Cl2/
CH3OH) Rf = 0.29; 1H NMR (360 MHz,
CDCl3) δ 1.32 (9H, s, C(CH3)3), 2.93 (2H, t, J
= 5.8 Hz, CH2SS), 3.93-3.99 (2H, m, 2′, 5′),
4.09-4.18 (3H, m, 5′′, OCH2CH2SS), 4.24-4.30
(1H, m, 4′), 4.33-4.41 (1H, m, 3′), 5.84 (1H, d,
J = 1.7 Hz, 1′), 7.48-7.62 (4H, m, 5, Ar),
7.87-7.89 (2H, m, Ar), 8.48 (1H, d, J = 7.5 Hz,
6), 9.01 (1H, br s, NH). 13C NMR (90 MHz,
CDCl3) δ 29.8 (C(CH3)3), 40.3 (CH2SS), 48.0
(C(CH3)3) ,  60.3 (5′) ,  67.8 (3′),  69.0
(OCH2CH2SS), 81.7 (2′), 85.0 (4′), 90.9 (1′),
96.7 (5), 127.6, 129.0, 132.9 (Ar), 133.3 (6),
146.4 (2), 162.5 (4). IR (film; NaCl) ν 3374,
2960, 2922, 1699, 1648, 1617, 1558, 1487,
1379, 1260, 1110 cm−1. FAB MS (3-NBA) m/z
496 (M+ + 1).
5′-O-(4, 4′-Dimethoxytrityl)-N4)-benzoyl)-
2′-O-(ethyl)cytidine tert-butyl disulfide (S.19).
TLC (1:1 acetone/petroleum ether) Rf = 0.23;
1H NMR (360 MHz, CD3CN) δ 1.30 (9H, s,
C(CH3)3), 2.95 (2H, t, J = 6.3 Hz, CH2SS),
3.39-3.44 (2H, m, OCH2CH2SS), 3.76 (6H, s,
2 OCH3), 3.90-4.03 (3H, m, 2′, 5′, 5′′), 4.12-
4.19 (1H, m, 4′), 4.39-4.47 (1H, m, 3′), 5.84
(1H, d, J = 1.7 Hz, 1′), 6.87-6.89 (4H, m, Ar),
7.15-7.61 (13H, m, 5, Ar), 7.92-7.95 (2H, m,
Ar), 8.46 (1H, d, J = 7.6 Hz, 6). 13C NMR (90
MHz, CD3CN) δ 30.2 (C(CH3)3), 41.0
(CH2SS), 48.5 (C(CH3)3), 56.0 (OCH3), 62.1
(5′), 68.9 (3′), 70.1 (OCH2CH2SS), 83.3 (2′),
83.6 (4′), 87.7 (OC(Ph)3), 90.2 (1′), 97.2 (5),
114.3, 128.1, 129.1, 129.1, 129.2, 129.7, 131.0,
131.2, (Ar), 133.9 (6), 134.5, 136.6, 137.0,
145.5 (Ar), 145.9 (2), 155.7, 159.8 (Ar), 163.9
(4), 168.2 (Ar). IR (KBr) ν 3392, 2959, 2924,
1700, 1667, 1610, 1553, 1510, 1482, 1377,
1252, 1113, 1033, 704 cm−1. MS (FAB, 3-
NBA) m/z 798 (M+ + 1).
5′-O-(4, 4′-Dimethoxytrityl)-N4)-benzoyl)-
2′-O-(ethyl)cytidine tert-butyl disulfide 3′-O-
(N,N-diisopropyl β cyanoethylphos-
phoramidite) (S.20). TLC (2:1 petroleum
ether/acetone) Rf = 0.40; 1H NMR (300 MHz,
CD3CN) δ (two diastereomers) 1.05-1.20
(12H, m, 2 NCH(CH3)2), 1.30 (9H, s, C(CH3)3),
2.50-2.67 (2H, m, OCH2CH2CN), 2.94-3.01
(2H, m, CH2SS),  3.41-3.71 (6H, m,
OCH2CH2SS, OCH2CH2CN, 2 NCH(CH3)2),
3.79 (6H, s, 2 OCH3), 3.80-4.22 (4H, m, 2′, 4′,
5′, 5′′), 4.43-4.63 (1H, m, 3), 5.88 (1H, s, 1′),
6.87-6.92 (4H, m, Ar), 7.03-7.66 (13H, m, 5,
Ar), 7.91-7.97 (2H, m, Ar), 8.42-8.55 (1H, 2 d,
J = 7.6 Hz, 6). 13C NMR (75 MHz, CD3CN) δ
(two diastereomers) 21.2, 21.3 (OCH2
CH2CN), 24.9, 25.0, 25.2, 25.3 (NCH(CH3)2),
30.3 (C(CH3)3), 41.4 (CH2SS), 44.1, 44.3
(NCH(CH3)2), 48.5 (C(CH3)3), 56.0 (OCH3),
59.3, 59.6 (OCH2CH2CN), 61.8, 62.2 (5′),
70.2, 70.4 (3′), 70.8 (OCH2CH2SS), 82.2 (2′),
83.1 (4′), 87.8 (OC(Ph)3), 90.8, 91.1 (1′), 97.3
(5), 114.2, 128.1, 129.0, 129.0, 129.3, 129.6,
131.2 (Ar), 133.8 (6), 134.5, 136.6, 136.7,
145.4 (Ar), 145.6 (2), 155.4, 159.8 (Ar), 163.6
(4). 31P NMR (202 MHz; CD3CN) δ 147.57,
146.51. IR (film; NaCl) ν 2967, 2934, 1708,
1686, 1509, 1510, 1462, 1251, 1180, 1035, 979
cm−1. MS (FAB, 3-NBA) m/z 998 (M+ + 1).
Anal. Calcd for C52H64N5O9PS2: C, 62.56; H,
6.48; N, 7.02. Found: C, 62.41; H, 6.41; N, 6.92.
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
2′-O-allyluridine (S.21). TLC (1:1 petroleum
ether/EtOAc) Rf 0.59; 1H NMR (360 MHz,
CDCl3) δ 1.01-1.11 (28H, m, isopropyl), 3.88
(1H, m, 4′), 3.98 (1H, dd, OCH2a), 4.18 (2H,
m, 2′,3′), 4.26 (1H, dd, OCH2b), 4.39 (2H, m,
5′,5′′), 5.21 (1H, ddd, =CH2a), 5.40 (1H, ddd,
=CH2b), 5.68 (1H, dd, 5), 5.76 (1H, s, 1′), 5.93
(1H, m, CH=), 7.93 (1H, d, 6), 9.14 (1H, s, NH);
13C NMR (90 MHz, CDCl3) δ 12.68-13.63
(isopropyl CHs), 17.00-17.70 (isopropyl
CH3s), 59.62 (5′), 68.25 (3′), 71.46 (OCH2),
81.27 (2′), 82.00 (4′), 89.29 (1′), 101.69 (5),
117.59 (=CH2), 134.51 (CH=), 139.77 (6),
150.06 (2), 163.61 (4); MS (DCI, CH4) m/z 527
(M+).
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
2′-O-(2,3-dihydroxypropyl)uridine (S.22).
TLC (51:4 CH2Cl2/CH3OH) Rf = 0.22; 1H
NMR (360 MHz, CDCl3) δ 1.02-1.10 (28H, m,
4 SiCH(CH3)2) ,  3 .65-3.75 (3H, m,
CH2CH(OH)CH2OH, CH2CH(OH)CH2OH),
3.86-4.04 (4H, m, 2′,  5′′,  CH2CH(OH)
CH2OH), 4.12-4.17 (2H, m, 3′, 4′), 4.25 (1H,
d, J = 13.6 Hz, 5′), 5.71 (1H, dd, J = 1.4, 8.1
Hz, 5), 5.74 (1H, d, J = 1.6 Hz, 1′), 7.88 (1H,
dd, J = 1.9, 8.1 Hz, 6). 13C NMR (75 MHz,
CDCl3) δ 13.07-13.90 (SiCH(CH3)2), 17.18-
17.82 (SiCH(CH3)2), 59.66 (5′), 68.58 (3′),
70.94 (CH2CH(OH)CH2OH), 74.20 (CH2CH
(OH)CH2OH), 82.22 (4′), 83.99 (CH2CH
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(OH)CH2OH), 89.43 (1′), 89.67 (2′), 102.33
(5), 139.24 (6), 150.82 (2), 163.33 (4). IR
(Nujol) ν 3424, 3160, 3092, 2951, 2946, 2935,
2925, 2918, 2909, 2896, 2891, 2873, 2867,
2863, 2856, 2850, 2726, 1693, 1685, 1462,
1378, 1272, 1163, 1125, 1062, 1035, 1010,
991, 884, 703 cm−1.
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
2′-O-(ethanal)uridine (S.23)  TLC (51:5
CH2Cl2/CH3OH) Rf = 0.48; 1H NMR (300
MHz, CDCl3) δ 1.03-1.12 (28 H, m, 4
SiCH(CH3)2), 3.71 (2 H, s, OCH2CHO), 3.95-
4.01 (2 H, m, 2′, 5′′), 4.23-4.30 (2 H, m, 3′,4′),
4.45-4.47 (1 H, m, 5′ ), 5.70 (1 H, dd, J = 2.2,
8.1 Hz, 5), 5.78 (1 H, s, 1′), 7.90 (1 H, d, J =
8.1 Hz, 6), 8.93 (1 H, s, NH). 13C NMR (75
MHz, CDCl3) δ 12.87-13.82 (SiCH(CH3)2),
17.11-17.78 (SiCH(CH3)2), 59.64 (5′), 68.95
(3′), 76.62 (OCH2CHO), 82.00 (4′), 83.85 (2′),
89.32 (1′), 102.03 (5), 139.41 (6), 150.18 (2),
163.21 (4), 200.35 (OCH2CHO). IR (KBr) ν
3482, 2947, 2868, 1700, 1685, 1464, 1386,
1272, 1256, 1166, 1131, 1096, 1063, 1056,
1038, 1012, 991, 886, 704 cm−1.
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
2′-O-(2-hydroxyethyl)uridine (S.24) .  TLC
(6:3:1 petroleum ether/EtOAc/CH3CN) Rf =
0.34; 1H NMR (360 MHz, CDCl3) δ 1.01-1.10
(28H, m, 4 SiCH(CH3)2), 3.74-3.76 (2H, m,
CH2CH2OH), 3.92-4.00 (4H, m, 2′,  5′,
CH2CH2OH), 4.17 (2H, m, 3′, 4′), 4.26 (1H, d,
J = 13.7 Hz, 5′), 5.70 (1H, d, J = 8.1 Hz, 5),
5.75 (1H, s, 1′), 7.90 (1H, d, J = 8.1 Hz, 6), 9.96
(1H, s, NH). 13C NMR (90 MHz, CDCl3) δ
12.73-13.62 (SiCH(CH3)2), 16.97-17.65
(SiCH(CH3)2),  59.46 (5′), 61.78 (OCH2
CH2OH), 68.37 (3′), 73.20 (OCH2CH2OH),
81.99 (4′), 83.04 (2′), 89.62 (1′), 101.99 (5),
139.38 (6), 150.58 (2), 163.80 (4). IR (KBr) ν
2946, 2869, 1701, 1464, 1387, 1271, 1165,
1129, 1094, 1062, 1039, 992, 885, 705 cm−1.
MS (CI, CH4) m/z 531 (M+).
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
2′-O-(ethyl-2-methylsulfonate)uridine (S.25)
TLC (17:3 CH2Cl2/acetone) Rf = 0.48; 1H NMR
(360 MHz, CDCl3) δ 1.03-1.12 (28H, m, 4
SiCH(CH3)2), 3.12 (3H, s, SCH3), 3.89 (1H, d,
J = 4.1 Hz, 2′), 3.97 (1H, dd, J = 2.2, 13.6 Hz,
5′), 4.10-4.15 (3H, m, 4′, OCH2CH2S), 4.20-
4.23 (1H, m, 3′), 4.26 (1H, d, J = 13.6 Hz, 5′′),
4.44-4.46 (2H, m, OCH2CH2S), 5.70 (1H, dd,
J = 2.1, 8.2 Hz, 5), 5.73 (1H, s, 1′), 7.91 (1H,
d, J = 8.2 Hz, 6), 8.95 (1H, s, NH). 13C NMR
(75 MHz, CDCl3) δ 12.85-13.74
(SiCH(CH3)2), 17.07-17.73 (SiCH(CH3)2),
38.00 (SCH3), 59.59 (5′), 68.63 (3′), 69.29
(OCH2CH2OMs), 69.44 (OCH2CH2OMs),
81.93 (4′), 83.27 (2′), 88.96 (1′), 101.97 (5),
139.38 (6), 150.33 (2), 163.60 (4). IR (KBr) ν
3213, 3065, 2947, 2869, 1699, 1465, 1355,
1272, 1179, 1129, 1095, 1065, 1040, 993, 885,
705 cm−1.
3′,5′-O-(Tetraisopropyldisiloxane-1,3-diyl)-
2′-O-(thiobenzoylethyl)uridine (S.26). TLC
(4:1 CH2Cl2/acetone) Rf = 0.68; 1H NMR (360
MHz, CDCl3) δ 1.00-1.10 (28H, m, 4
SiCH(CH3)2), 3.36 (2H, m, OCH2CH2S), 3.91
(1H, d, J = 3.3 Hz, 2′), 3.99 (1H, dd, J = 1.5,
13.6 Hz, 5′), 4.02-4.06 (2H, m, OCH2CH2S),
4.18 (2H, m, 3′, 4′), 4.25 (1H, d, J = 13.6 Hz,
5′′), 5.68 (1H, dd, J = 1.7, 8.2 Hz, 5), 5.73 (1H,
s, 1′), 7.44 (2H, m, Ar), 7.56 (1H, m, Ar), 7.90
(1H, d, J = 8.2 Hz, 6), 7.96 (1H, m, Ar), 9.47
(1H, s, NH). 13C NMR (90 MHz, CDCl3) δ
12.71-13.62 (SiCH(CH3)2), 17.00-17.70
(SiCH(CH3)2), 29.16 (OCH2CH2S), 59.57 (5′),
68.45 (3′), 70.12 (OCH2CH2S), 81.88 (4′),
82.60 (2′), 89.34 (1′), 101.71 (5), 127.45,
128.74, 133.53, 137.18 (Ar), 139.73 (6),
150.14 (2), 163.92 (4), 191.67 (CO). IR (KBr)
ν 3205, 3058, 2945, 2868, 1699, 1463, 1387,
1271, 1207, 1164, 1126, 1093, 1064, 1040,
914, 885, 705, 690 cm−1.
2′-O-(Thiobenzoylethyl)uridine (S.27).
TLC (9:1 CH2Cl2/CH3OH) Rf = 0.14; 1H NMR
(360 MHz, CD3OD) δ 3.27-3.38 (2H, m,
OCH2CH2S), 3.75 (1H, dd, J = 3.0, 12.4 Hz,
5′), 3.82-3.96 (2H, m, 2′, 5′′), 3.99-4.02 (1H,
m, 4′), 4.05-4.09 (2H, m, OCH2CH2S), 4.24
(1H, m, 3′), 5.67 (1H, d, J = 8.1 Hz, 5), 5.95
(1H, d, J = 3.7 Hz, 1′), 7.49 (2H, m, ArH), 7.62
(1H, m, ArH), 7.93 (2H, m, ArH), 8.06 (1H, d,
J = 8.1 Hz, 6). 13C NMR (90 MHz, CD3OD)
δ 29.70 (ΟΧΗ2CH2S), 61.77 (5′), 70.01 (3′),
70.65 (OCH2CH2S), 83.80 (4′), 86.26 (2′),
89.31 (1′), 102.74 (5), 128.27, 130.04,
134.94, 138.30 (Ar), 142.58 (6), 152.35 (2),
166.36 (4), 193.18 (CO). IR (KBr) ν 3473,
3422, 3168, 3107, 3051, 2954, 2916, 2874,
2860, 2572, 2540, 1693, 1672, 1647, 1615,
1446, 1388, 1267, 1209, 1143, 1111, 1098,
915, 770, 687 cm−1. MS (CI, CH4) m/z 409
(M+ + 1).
5′-O-(4,4′-Dimethoxytrityl)-2′-O-(thiobenzoyl-
ethyl)uridine (S.28) .  TLC (19:1
CH2Cl2/CH3OH) Rf = 0.59. 1H NMR (360
MHz, CD3CN) δ 3.30-3.41 (5H, m, 2′, 5′, 5′′,
OCH2CH2S), 3.75 (6H, s, 2 OCH3), 3.87-3.99
(3H, m, 4′, OCH2CH2S) 4.01-4.04 (1H, m, 3′),
5.24 (1H, d, J = 8.2 Hz, 5), 5.83 (1H, d, J = 1.7
Hz, 1′), 6.87 (4H, m, ArH), 7.21-7.33 (9H, m,
ArH), 7.41-7.52 (5H, m, ArH), 7.61-7.66 (1H,
m, ArH), 7.74 (1H, d, J = 8.2 Hz, 6), 7.93-7.96
(4H, m, ArH). 13C NMR (90 MHz, CD3CN) δ
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17.03 (OCH2CH2S), 56.02 (OCH3), 63.11 (5′),
69.86 (3′), 70.28 (OCH2CH2S), 83.21 (2′),
84.04 (4′), 87.65 (OC(Ph)3), 88.68 (1′), 102.55
(5), 114.24 (Ar), 128.06, 129.02, 129.14,
129,98, 131.17, 131.64, 134.81, 136.49,
136.73, 137.89 (Ar), 141.17 (6), 145.87 (Ar),
151.41 (2), 159.86 (Ar), 161.07 (4), 192.35
(SC(O)Ph). MS (CI, CH4) m/z 710 (M+).
5′-O-(4,4′-Dimethoxytrityl)-2′-O-(ethyl)-
uridine tert-butyl disulfide (S.29) TLC (49:1
CH2Cl2/CH3OH) Rf = 0.12; 1H NMR (360
MHz, acetone-d6) δ 1.32 (9H, s, C(CH3)3) 3.00
(2H, t, J = 6.5 Hz, OCH2CH2S), 3.48 (2H, m,
5′, 5′′), 3.80 (6 H, s, OCH3), 3.94-4.07 (4H, m,
2′, 3′, OCH2CH2S), 4.15-4.17 (1H, m 4′), 5.29
(1H, d, J = 8.1 Hz, 5), 5.94 (1H, d, J = 2.5 Hz,
1′), 6.90-6.93 (4H, m, ArH), 7.32-7.37 (7H, m,
ArH), 7.47-7.50 (2H, m, ArH), 7.92 (1H, d, J
= 8.1 Hz, 6). 13C NMR (90 MHz, acetone-d6)
δ 29.28-30.56 (acetone, C(CH3)3), 40.79
(OCH2CH2S),  48.32 (C (CH3)3), 55.61
(OCH3),  63.15 (5′) ,  69.94 (3′),  70.16
(OCH2CH2S), 83.30 (2′), 84.03 (4′), 87.58
(Ar), 88.75 (1′), 102.41 (5), 114.09, 127.83,
128.82, 129.13, 131.14, 136.37, 136.67 (Ar),
140.88 (6), 145.93 (Ar), 151.29 (2), 159.80
(Ar), 163.58 (4). MS (FAB, 3-NBA) m/z 695
(M+ + 1).
3′-O-(N,N-Diisopropyl-β-cyanoethylphos-
phoramidite)-5′-O-(4,4′-dimethoxytrityl)-2-
O-(ethyl)uridine tert-butyl disulfide (S.30).
TLC (2:1 petroleum ether/acetone) Rf = 0.34;
1H NMR (360 MHz, CD3CN) δ (two dias-
tereomers) 1.04-1.06 (4H, m, 2 NCH(CH3)2),
1.14-1.18 (12H, m, 2 NCH(CH3)2), 1.30, 1.31
(9H, 2 s, SSC(CH3)3), 2.51-2.69 (2H, m,
OCH2CH2CN),  2 .89-2.94 (2H,  m,
OCH2CH2S) ,  3 .37-3 .44  (2H,  m,
OCH2CH2CN), 3.58-3.66 (2H, m, 5′, 5′′),
3.76, 3.77 (6H, 2 s, OCH3), 3.80-3.95 (2H,
m, OCH2CH2S), 4.06-4.12 (2H, m, 2′,4′),
4.40-4.53 (1H, m, 3′), 5.20, 5.21 (1H, 2 d, J
= 8.1 Hz, 5), 5.85 (1H, m, 1′), 6.86-6.90 (4H,
m, ArH), 7.25-7.36 (7H, m, ArH), 7.42-7.47
(2H, m ArH), 7.73,7.82 (1H, 2 d, J = 8.1 Hz,
6). 13C NMR (75 MHz, acetone-d6) δ (two
diastereomers) 20.96 (NCH(CH3)2), 25.02-
25.32 (NCH(CH3)2), 29.14-30.68 (acetone,
SSC(CH3)3), 41.17 (OCH2CH2S), 44.07,
44.24 (CH2CN), 48.27 (SSC(CH3)3), 55.68
(OCH3), 59.25-59.92 (POCH2), 62.72, 63.00
(5′), 70.27, 70.41 (OCH2CH2S), 71.30, 71.48
(3′), 82.11, 82.81 (2′), 83.14-83.41 (4′), 87.78
(Ar), 89.04, 89.29 (1′), 102.53, 102.59 (5),
114.10 (Ar), 118.81, 118.96 (CN), 127.80,
128.72, 129.19, 131.15, 131.53, 136.27,
136.35, 136.45 (Ar), 140.65, 140.72 (6),
145.68, 145.75 (Ar), 151.21 (2), 159.80 (Ar),
163.37 (4). 31P NMR (202 MHz, CD3CN) δ
147.44, 146.90. IR (KBr) ν 3199, 3059, 2966,
2932, 2871, 2837, 2248, 1692, 1608, 1615,
1510, 1458, 1364, 1253, 1179, 1119, 1085,
1070, 1035, 980, 828, 810 cm−1. MS (FAB,
3-NBA) m/z 895 (M+ +1). Anal. Calcd for
C45H59N4O9PS2: C, 60.38. H, 6.64. N, 6.26.
Found: C, 60.59. H, 6.59. N, 5.95.
Critical Parameters
There are three critical parameters for the
formation of intramolecular disulfide bonds in
RNA. First, prior to oxidation the reducing
agent used to remove the thiol protecting
groups, DTT, must be entirely removed from
sample. Second, the concentration of the RNA
must be very low (1 to 4 µM) to avoid intermo-
lecular cross-link formation. Third, for efficient
cross-link formation the pH of the solution
must be maintained between 8.0 and 8.4. At pH
values <8.0 the concentration of thiolate ion
will be reduced and the rate of cross-link for-
mation will be reduced. However, prolonged
exposure of the RNA to pH values >8.4 may
lead to degradation.
Troubleshooting
See Table 5.4.1 for discussion of common
problems encountered with these procedures
and methods to identify, solve, and avoid them.
Anticipated Results
The authors have achieved 100% conversion
of tert-butyl disulfide–protected tRNAs to in-
tramolecularly disulfide-cross-linked tRNAs at
three different sites of disulfide incorporation.
Similar results should be obtained for thiols
positioned at proximal locations either in a
folded tertiary structure or within secondary
structure.
The solid-phase synthesis of tRNAs con-
taining the thiol-modified nucleosides de-
scribed here results in yields of 0.5 mg tRNA
after purification to single-nucleotide resolu-
tion. Each thiol-modified nucleoside is incor-
porated into the RNA oligomer as efficiently as
commercially available phosphoramidites.
Time Considerations
Conversion of the tert-butyl disulfide–pro-
tected RNA to disulfide-cross-linked RNA
takes 36 to 48 hr; both the reduction of the
tert-butyl disulfide protecting groups and the
air oxidation can be done as overnight reac-
tions. To ensure complete reduction of the
tert-butyl disulfide protecting groups the
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RNA should be incubated with DTT for ≥12
hr, while >14 hr appears unnecessary. The
slow rate of dialysis (5 mL/min), using 3 L
of buffer over 10 hr, ensures that the DTT is
completely removed and that the buffer ex-
change into the lower-salt buffer is complete.
Cross-link formation between thiols posi-
tioned at locations that are proximal in the
folded RNA generally occurs in <12 hr. It has
taken up to 48 hr for completion of some
cross-linking reactions; in such cases the pH
is monitored periodically and adjusted as
necessary, and water is also added to com-
pensate for evaporation.
Synthesis and purification of thiol-modified
tRNA takes between 1 and 2 weeks depending
on the amount of RNA to be purified before
proceeding with the cross-linking reaction.
This includes 1 day to synthesize the necessary
phosphoramidites before commencing the
solid-phase synthesis.
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